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A B S T R A C T
Background
Early dental decay or demineralised lesions (DLs, also known as white spot lesions) can appear on teeth during fixed orthodontic (brace)
treatment. Fluoride reduces decay in susceptible individuals, including orthodontic patients. This review compared various forms of top-
ical fluoride to prevent the development of DLs during orthodontic treatment. This is the second update of the Cochrane Review first pub-
lished in 2004 and previously updated in 2013.
Objectives
The primary objective was to evaluate whether topical fluoride reduces the proportion of orthodontic patients with new DLs after fixed
appliances.
The secondary objectives were to examine the effectiveness of different modes of topical fluoride delivery in reducing the proportions of
orthodontic patients with new DLs, as well as the severity of lesions, in terms of number, size and colour. Participant-assessed outcomes,
such as perception of DLs, and oral health-related quality of life data were to be included, as would reports of adverse effects.
Search methods
Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 1 February
2019), the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 1) in the Cochrane Library (searched 1 February 2019),
MEDLINE Ovid (1946 to 1 February 2019), and Embase Ovid (1980 to 1 February 2019). The US National Institutes of Health Ongoing Trials
Register (ClinicalTrials.gov) and the World Health Organization International Clinical Trials Registry Platform were searched for ongoing
trials. No restrictions were placed on the language or date of publication when searching the electronic databases.
Selection criteria
Parallel-group, randomised controlled trials comparing the use of a fluoride-containing product versus a placebo, no treatment or a dif-
ferent type of fluoride treatment, in which the outcome of enamel demineralisation was assessed at the start and at the end of orthodontic
treatment.
Data collection and analysis
At least two review authors independently, in duplicate, conducted risk of bias assessments and extracted data. Authors of trials were
contacted to obtain missing data or to ask for clarification of aspects of trial methodology. Cochrane's statistical guidelines were followed.
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Main results
This update includes 10 studies and contains data from nine studies, comparing eight interventions, involving 1798 randomised partici-
pants (1580 analysed). One report contained insufficient information and the authors have been contacted.
We assessed two studies as at low risk of bias, six at unclear risk of bias, and two at high risk of bias.
Two placebo (non-fluoride) controlled studies, at low risk of bias, investigated the professional application of varnish (7700 or 10,000 parts
per million (ppm) fluoride (F)), every six weeks and found insufficient evidence of a difference regarding its effectiveness in preventing new
DLs (risk ratio (RR) 0.52, 95% confidence interval (CI) 0.14 to 1.93; 405 participants; low-certainty evidence). One placebo (non-fluoride)
controlled study, at unclear risk of bias, provides a low level of certainty that fluoride foam (12,300 ppm F), professionally applied every
two months, may reduce the incidence of new DLs (12% versus 49%) after fixed orthodontic treatment (RR 0.26, 95% CI 0.11 to 0.57; 95
participants).
One study, at unclear risk of bias, also provides a low level of certainty that use of a high-concentration fluoride toothpaste (5000 ppm F)
by patients may reduce the incidence of new DLs (18% versus 27%) compared with a conventional fluoride toothpaste (1450 ppm F) (RR
0.68, 95% CI 0.46 to 1.00; 380 participants).
There was no evidence for a difference in the proportions of orthodontic patients with new DLs on the teeth after treatment with fixed
orthodontic appliances for the following comparisons:
- an amine fluoride and stannous fluoride toothpaste/mouthrinse combination versus a sodium fluoride toothpaste/mouthrinse,
- an amine fluoride gel versus a non-fluoride placebo applied by participants at home once a week and by professional application every
three months,
- resin-modified glass ionomer cement versus light-cured composite resin for bonding orthodontic brackets,
- a 250 ppm F mouthrinse versus 0 ppm F placebo mouthrinse,
- the use of an intraoral fluoride-releasing glass bead device attached to the brace versus a daily fluoride mouthrinse.
The last two comparisons involved studies that were assessed at high risk of bias, because a substantial number of participants were lost
to follow-up.
Unfortunately, although the internal validity and hence the quality of the studies has improved since the first version of the review, they
have compared different interventions; therefore, the findings are only considered to provide low level of certainty, because none has
been replicated by follow-up studies, in different settings, to confirm external validity.
A patient-reported outcome, such as concern about the aesthetics of any DLs, was still not included as an outcome in any study. Reports
of adverse effects from topical fluoride applications were rare and unlikely to be significant. One study involving fluoride-containing glass
beads reported numerous breakages.
Authors' conclusions
This review found a low level of certainty that 12,300 ppm F foam applied by a professional every 6 to 8 weeks throughout fixed ortho-
dontic treatment, might be effective in reducing the proportion of orthodontic patients with new DLs. In addition, there is a low level of
certainty that the patient use of a high fluoride toothpaste (5000 ppm F) throughout orthodontic treatment, might be more effective than
a conventional fluoride toothpaste. These two comparisons were based on single studies. There was insufficient evidence of a difference
regarding the professional application of fluoride varnish (7700 or 10,000 ppm F). Further adequately powered, randomised controlled
trials are required to increase the certainty of these findings and to determine the best means of preventing DLs in patients undergoing
fixed orthodontic treatment. The most accurate means of assessing adherence with the use of fluoride products by patients and any pos-
sible adverse effects also need to be considered. Future studies should follow up participants beyond the end of orthodontic treatment
to determine the effect of DLs on patient satisfaction with treatment.
P L A I N   L A N G U A G E   S U M M A R Y
Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment
Review question
Ugly white or brown marks sometimes appear on the teeth during treatment with braces to straighten teeth. These are due to early tooth
decay and usually occur with fixed, glued-on 'train track', braces, which make it more difficult to clean the teeth.
We know that fluoride in toothpaste helps to prevent tooth decay and think that if extra fluoride is given to people wearing fixed braces, it
will protect them from getting these marks. The aim of this Cochrane Oral Health's review was to look at how well fluorides help to prevent
early tooth decay during fixed brace treatment and to find out the best way to get fluoride to the teeth.
Background
Wearing a fixed brace makes it harder for people to keep their teeth clean and may also cause pain. Pain can make it more difficult for
people to brush their teeth. This can lead to a build-up of dental plaque around the brackets that attach the fixed brace to the teeth, and
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if the plaque stays on the tooth for long enough, it will cause early tooth decay, which looks like white or brown marks (demineralised
lesions, also known as white spot lesions). People often wear braces for 18 months or longer and if the decay is leJ to progress, it can cause
holes, which are sometimes bad enough to need fillings to be done in the teeth.
Fluoride helps the tooth to heal, reducing tooth decay in people who are at risk of developing it. People receiving fixed brace treatment
may be given different forms of fluoride treatment. It is important to think about how the fluoride gets to the teeth. Does the fluoride need
to be placed by a dentist or dental nurse, or can people having treatment with braces apply the fluoride to their own teeth?
Study characteristics
This review is up-to-date as of 1 February 2019. The review includes 10 studies but we could only use the information from nine studies
involving 1798 randomised people. We have asked for more information about one study. The review looks at eight different ways of
applying fluoride to the teeth. People taking part in the studies were all having treatment with fixed braces. The number of people with
new decay on the teeth at end of fixed brace treatment, as well as the amount of decay in each person, were measured and counted.
We compared the following treatments:
- dentist or nurse-applied fluoride e.g. varnish, gel or foam,
- patient-applied/used fluoride e.g. toothpaste, mouthwash, gel or foam, and
- materials that release fluoride over time e.g. glues, elastic bands.
Key results
One study showed that when the dentist applies a foam with a high level of fluoride in it onto the teeth every time the patient is seen, this
might reduce the risk of new decay. Another study found that if patients use a toothpaste with a higher level of fluoride than normal, then
this might also reduce the risk of new marks on their teeth.
No studies have shown that other ways of giving the teeth extra fluoride reduced the number and/or size of new decay on teeth in people
wearing fixed braces. Harmful effects of the different ways of giving the teeth more fluoride were not reported in any of the included studies.
Certainty of the evidence
The level of belief we have in these findings is low, due to the lack of studies testing the same fluorides and showing the same results. We
suggest that more, well-conducted studies should be done in this area.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Dentist/nurse-applied fluoride: fluoride varnish compared to non-fluoride (placebo) varnish for
preventing early tooth decay (demineralised lesions) during fixed brace treatment
Fluoride varnish compared to non-fluoride (placebo) varnish for preventing early tooth decay (demineralised lesions) during fixed brace treatment
Patient or population: orthodontic patients (any age)
Setting: orthodontic clinics in Sweden
Intervention: fluoride varnish
Comparison: non-fluoride (placebo) varnish
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Number of participants with adverse ef-
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CI: confidence interval; DLs: demineralised lesions; F: fluoride; ppm: parts per million; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
aDowngraded 1 level for indirectness (evidence from only 2 studies) (Stecksén-Blicks 2007; Sonesson 2019).
bDowngraded 1 level for imprecision (insufficient number of participants with new DLs (guideline 300 to 400 events)).
cDowngraded 1 level for imprecision (insufficient number of participants with the more severe DLs (guideline 300 to 400 events)).
dDowngraded 1 level for indirectness (evidence from only 1 study) (Sonesson 2019).
eDowngraded 1 level for imprecision (insufficient number with adverse events and not clear if directly related to the intervention).
 
 
Summary of findings 2.   Dentist/nurse-applied fluoride: 12,300 ppm F APF foam compared to 0 ppm F placebo foam for preventing early tooth decay
(demineralised lesions) during fixed brace treatment
12,300 ppm F APF foam compared to 0 ppm F placebo foam for preventing early tooth decay (demineralised lesions) during fixed brace treatment
Patient or population: orthodontic patients (any age)
Setting: orthodontic department at dental hospital in China
Intervention: 12,300 ppm F APF foam
Comparison: 0 ppm F placebo foam
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The evidence suggests that
when foam, containing 12,300
ppm F, is applied by a dentist
or a nurse, every 2 months, to
the teeth of patients wearing
fixed orthodontic appliances
there might be a reduction in
the number of patients who
have at least 1 new DL
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Number of participants with adverse effects
(adverse effects)
None of the trials reported this outcome
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
APF: acidulated phosphate fluoride; CI: confidence interval; DLs: demineralised lesions; F: fluoride; ppm: parts per million; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
aAlthough effect size is large this was only for 1 study at unclear risk of bias and therefore downgraded 1 level (Jiang 2013).
bDowngraded 1 level for imprecision (insufficient number of participants with new DLs (guideline 300 to 400 events)).
 
 
Summary of findings 3.   Patient-applied/used fluoride: 5000 ppm F toothpaste compared to 1450 ppm F toothpaste for preventing early tooth decay
(demineralised lesions) during fixed brace treatment
5000 ppm F toothpaste compared to 1450 ppm F toothpaste for preventing early tooth decay (demineralised lesions) during fixed brace treatment
Patient or population: orthodontic patients (any age)
Setting: home use
Intervention: 5000 ppm F toothpaste
Comparison: 1450 ppm F toothpaste
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The evidence suggests that in pa-
tients wearing an orthodontic fixed
brace use of a daily 5000 ppm F
toothpaste compared with a daily
1450 ppm F toothpaste throughout
treatment may lead to a reduction in



















































































































Number of participants with more
severe DLs (severity of DLs)
None of the trials reported this outcome
Number of participants with adverse
effects (adverse effects)
None of the trials reported this outcome
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; DLs: demineralised lesions; F: fluoride; ppm: parts per million; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
aDowngraded 1 level due to single study at unclear risk of bias (Sonesson 2014).
bDowngraded 1 level for imprecision (insufficient number of participants with new DLs (guideline 300 to 400 events)).
 
 
Summary of findings 4.   Patient-applied/used fluoride: 250 ppm F mouthrinse (100 ppm F amine F/150 ppm NaF) compared to 0 ppm F placebo
mouthrinse for preventing early tooth decay (demineralised lesions) during fixed brace treatment
250 ppm F mouthrinse (100 ppm amine F/150 ppm NaF) compared to 0 ppm F placebo mouthrinse for preventing early tooth decay (demineralised lesions) during
fixed brace treatment
Patient or population: orthodontic patients (any age)
Setting: home use
Intervention: 250 ppm F mouthrinse (100 ppm amine F/150 ppm NaF)
Comparison: 0 ppm F placebo mouthrinse







































The evidence is very uncer-
tain about the effect of a
daily 250 ppm F mouthrinse
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Follow-up: 24.5 months a daily 0 ppm F placebo
mouthrinse on the number
of patients wearing a fixed
orthodontic brace with new
DLs
Number of participants with more se-
vere DLs (severity of DLs)
None of the trials reported this outcome
Number of participants with adverse ef-
fects (adverse effects)
None of the trials reported this outcome
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; DLs: demineralised lesions; F: fluoride; NaF: sodium fluoride; ppm: parts per million; QLF: quantitative light-induced fluorescence; RCT: ran-
domised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
aDowngraded 2 levels: single study with a relatively small number of participants (81), at high risk of bias due to high attrition (33%) (van der Kaaij 2015).
bDowngraded 1 level for imprecision (insufficient number of participants with new DLs (guidance 300 to 400 events)).
 
 
Summary of findings 5.   Fluoride-releasing materials: resin-modified glass ionomer cement compared to light-cured composite resin for bonding
orthodontic brackets for preventing early tooth decay (demineralised lesions) during fixed brace treatment
Resin-modified glass ionomer cement compared to light-cured composite resin for bonding orthodontic brackets for preventing early tooth decay (demineralised
lesions) during fixed brace treatment
Patient or population: orthodontic patients (any age)
Setting: 2 dental teaching hospitals and 4 specialist orthodontic practices in UK and Republic of Ireland
Intervention: resin-modified glass ionomer cement
Comparison: light-cured composite resin
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ionomer cement for bond-
ing orthodontic brackets
compared with light-cured
composite resin results in
little to no difference in
the number of orthodon-
tic patients with new DLs
Number of participants with more severe DLs of
aesthetic concern (severity of DLs)
Assessed with: pre-treatment and day of






















resin results in little to no
difference in the number
of orthodontic patients
with more severe DLs of
aesthetic concern
Number of participants with adverse effects
(adverse effects)
Follow-up: 17.6 months





*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; DLs: demineralised lesions; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
aDowngraded 1 level: single study at unclear risk of bias (Benson 2019).
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B A C K G R O U N D
Description of the condition
During orthodontic treatment with fixed appliances, brackets are
attached to the teeth to hold the wires that provide the forces
to straighten the teeth. One of the adverse effects of fixed braces
is that dental plaque collects around the attachments, leading
to accumulation of the types of bacteria that cause dental dis-
ease (Naranjo 2006). Build-up of dental plaque around orthodontic
brackets is associated with increased risk of demineralised lesions
(DLs, also known as white spot lesions), which can be visible with-
in six months (Tufekci 2011). Demineralisation is an early, but re-
versible, stage in the development of dental decay (caries). Cario-
genic bacteria present in the dental plaque change sugar in the di-
et into organic acids, which start to damage the tooth enamel. Ef-
fective removal of plaque will prevent DLs from occurring; howev-
er, the presence of orthodontic appliances in the mouth and asso-
ciated dental pain may make it more difficult for individuals to ad-
equately clean their teeth and braces. DLs developing on the labi-
al and buccal surfaces of teeth during orthodontic treatment can
become a significant problem over the course of treatment, which
may last for 18 months or longer, resulting in a poor appearance
of the teeth following straightening (Maxfield 2012). In severe cas-
es the caries can make a hole in the tooth that will require a filling
(restoration), which may be both painful and costly.
Enaia and colleagues (Enaia 2011) used clinical photographs of the
teeth taken before and after fixed brace treatment to show that
whereas 32% of people in their study had DLs before the brace was
fitted, this rose to 74% after their braces had been taken oG. Most of
the DLs were minor, but a significant minority of participants (10%)
had holes in their teeth, which may have required a filling. Although
DLs tend to fade with time as they heal, one study has shown that,
even five years after treatment, a significant proportion of people
who had worn fixed braces showed some evidence of DLs caused by
the braces compared with a control group of people who had not
had a fixed brace (Ogaard 1989).
Description of the intervention
Orthodontists are keen to prevent the development of DLs so their
patients may have the best possible appearance after orthodontic
treatment - straight teeth with no marks. Fluoride is important in
the prevention of dental decay (ten Cate 2013). Marinho and col-
leagues (Marinho 2016) found a definite reduction in dental de-
cay in children and adolescents who performed regular supervised
rinsing with a fluoride mouthwash. It has also been shown that fluo-
ride may reduce the number of DLs that develop during brace treat-
ment. When orthodontic participants used a mouthrinse, Geiger et
al (Geiger 1992) found a 30% reduction in the number of partici-
pants with DLs and a 25% reduction in the incidence of teeth affect-
ed by DLs. Many orthodontists recommend the use of a daily fluo-
ride mouthrinse throughout brace treatment to prevent DLs (Ker-
busch 2012).
Several methods (in addition to fluoridated toothpaste) are used to
deliver fluoride to teeth in patients during orthodontic treatment.
These include the following:
• topical fluorides (e.g. mouthrinse, gel, varnish or foam) that are
applied by the dentist or nurse when the orthodontic patient is
seen to adjust their brace;
• topical fluorides (e.g. toothpaste, mouthrinse, gel or foam) that
the orthodontic patient can apply themselves at home;
• fluoride-releasing materials (e.g. glues used to bond the brack-
ets onto the teeth and orthodontic elastics that are impregnat-
ed with fluoride);
• dietary fluoride supplementation (e.g. fluoridated milk).
How the intervention might work
Fluoride present in the mouth reduces caries development via
three mechanisms: inhibition of the demineralisation of dental
enamel, enhancement of the remineralisation of dental enamel
producing a remineralised layer that is resistant to acid attack, and
inhibition of the bacterial enzymes that produce the acid (Lynch
2006; ten Cate 2013).
Most children undergoing orthodontic treatment will be exposed
to some fluoride - low concentrations in the water supply, higher
concentrations from fluoridated toothpaste, or both. Use of oth-
er topical fluorides or fluoride sources designed to deliver addi-
tional fluoride to the at-risk area, or both, near orthodontic brack-
ets, are likely to further reduce the risk of DL development. Topical
fluorides include fluoride toothpastes, mouthrinses, gels, varnish-
es and dietary sources (e.g. fluoridated milk). Specific orthodontic
sources of fluoride include bracket adhesives and orthodontic elas-
tic bands (elastomeric ligatures), which slowly release fluoride into
the mouth. All of these fluoride sources release fluoride into saliva
that is distributed throughout the mouth.
Why it is important to do this review
Several systematic reviews have concluded that the use of topical
fluoride in various forms reduce the prevalence and incidence of
dental caries in children and adolescents (Marinho 2003a; Marin-
ho 2003b; Marinho 2004; Marinho 2016). Orthodontists have, there-
fore, routinely recommended the use of topical fluoride mouthrins-
es to their patients wearing fixed appliances or apply fluoride in the
form of varnish, gel or foam to reduce the risk of orthodontic pa-
tients developing dental caries. Others use fluoride-releasing ma-
terials to attach the brackets or bands to the teeth. Clear evidence
is lacking, regarding the optimum concentration of topical fluoride,
the optimum frequency of use and the effects of topical fluorides
and fluoride-releasing materials over the whole length of ortho-
dontic treatment.
This Cochrane Review was first published in 2004 (Benson 2004).
It was updated in 2013 with an amended protocol to only include
appropriately designed randomised studies, using parallel groups
and measuring relevant outcomes over the full length of orthodon-
tic treatment (Benson 2013). This is the second update.
O B J E C T I V E S
The primary objective of this review was to evaluate whether top-
ical fluoride reduces the proportion of orthodontic patients with
new demineralised lesions (DLs) after fixed appliances.
The secondary objectives were to examine the effectiveness of dif-
ferent modes of fluoride delivery in reducing the proportions of or-
thodontic patients with new DLs, as well as the severity of lesions, in
terms of number, size and colour. Participant-assessed outcomes,
such as perception of DLs, and oral health-related quality of life da-
ta were to be included, as would reports of adverse effects.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) in which fluoride
was delivered by any method to prevent the development of new
enamel demineralised lesions (DLs) during fixed orthodontic treat-
ment. As topical fluorides are distributed throughout the mouth by
saliva, the use of a within-person or split-mouth study design to
evaluate these interventions is inappropriate, due to potential car-
ry-across effects (Pandis 2013) and any study using this design was
excluded. Studies involving multiple arms would be examined and
only comparisons between two fluoride interventions or fluoride
versus no fluoride interventions would be included in the pairwise
analysis.
Types of participants
Included were participants of any age who had orthodontic treat-
ment with fixed braces in situations where DLs were assessed on
teeth remaining in the mouth at the end of orthodontic treatment
(at debonding, immediately after the active fixed brace is removed).
We excluded studies that evaluated demineralisation of extracted
teeth (ex vivo) or that were undertaken over short periods of time
i.e. less than the whole time the fixed brace was in the mouth.
Types of interventions
• Topical fluoride in the form of toothpaste, mouthrinse, gel, var-
nish, foam or dietary sources at any dose, frequency, duration
or method of administration, and with any of the following ac-
tive agents/ingredients: NaF (sodium fluoride), SMFP (sodium
monofluorophosphate), SnF (stannous fluoride), APF (acidulat-
ed phosphate fluoride) and amine F (amine fluoride) applied ei-
ther by a professional in the dental surgery or office, or used by
the patient at home.
• Materials containing fluoride that is potentially released during
treatment, including fluoride-releasing composite resin-bond-
ing materials, compomers, glass ionomer cements and resin-
modified glass ionomers for bonding or banding, slow-release
fluoride beads/devices and fluoride-releasing elastomeric liga-
tures.
• The control group comprising of individuals not subjected to the
fluoride intervention, but instead treated with a placebo, such
as a non-fluoride toothpaste and mouthrinse, or given no inter-
vention. Studies involving a control subjected to an alternative
fluoride intervention were also included.
Types of outcome measures
Primary outcomes
• The primary outcome was the difference in the proportion of
participants in the experimental and comparison groups with
new DLs on the day the fixed appliance was removed.This could
be assessed directly from the participant (clinically) or prefer-
ably from start and finish photographs or fluorescent images of
the teeth immediately after the active fixed brace was removed.
If the number of DLs was not recorded at the start of treatment,
the outcome was the presence or absence of DLs at the end of
orthodontic treatment, again assessed directly from the partic-
ipant or indirectly from photographs or fluorescent images of
the teeth. It is important that the assessment was carried out on
the day the appliance was removed (or as close to this as pos-
sible), because the white marks will tend to heal (remineralise)
after the brace is removed. The rate at which the DLs reminer-
alise can be variable between individuals and is another poten-
tial confounding factor.
Secondary outcomes
• Differences in the severity of the new DLs, as assessed by num-
ber, size and colour between experimental and control groups
at the end of orthodontic treatment.
• Any quantitative assessment of enamel mineral loss, such as flu-
orescent light techniques or microradiography, used with in situ
caries models (Benson 2010) at the end of treatment.
• Any participant-assessed outcomes, such as perception of DLs
and oral health-related quality of life data.
• Adverse effects.
Search methods for identification of studies
Electronic searches
Cochrane Oral Health's Information Specialist conducted system-
atic searches in the following databases for randomised controlled
trials and controlled clinical trials. There were no language, publi-
cation year or publication status restrictions:
• Cochrane Oral Health's Trials Register (searched 1 February
2019) (Appendix 1);
• Cochrane Central Register of Controlled Trials (CENTRAL; 2019,
Issue 1) in the Cochrane Library (searched 1 February 2019) (Ap-
pendix 2);
• MEDLINE Ovid (1946 to 1 February 2019) (Appendix 3);
• Embase Ovid (1980 to 1 February 2019) (Appendix 4).
Subject strategies were modelled on the search strategy designed
for MEDLINE Ovid. Where appropriate, they were combined with
subject strategy adaptations of the highly sensitive search strate-
gy designed by Cochrane for identifying randomised controlled tri-
als and controlled clinical trials as described in the Cochrane Hand-
book for Systematic Reviews of Interventions Chapter 6 (Lefebvre
2011).
Searching other resources
The following trial registries were searched for ongoing studies (see
Appendix 5 for details of the search terms used):
• US National Institutes of Health Ongoing Trials Register Clinical-
Trials.gov (clinicaltrials.gov; searched 1 February 2019);
• World Health Organization International Clinical Trials Registry
Platform (apps.who.int/trialsearch; searched 1 February 2019).
We searched the reference lists of included studies and relevant
systematic reviews for further studies.
We checked that none of the included studies in this review were
retracted due to error or fraud.
We did not perform a separate search for adverse effects of inter-
ventions used, we considered adverse effects described in includ-
ed studies only.
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Data collection and analysis
Selection of studies
The search was designed to be sensitive and include controlled clin-
ical trials, these were filtered out early in the selection process if
they were not randomised.
Two review authors independently examined the title, keywords
and abstract of reports identified through electronic searching for
evidence of three criteria.
• A randomised clinical trial of participants undergoing orthodon-
tic treatment with fixed appliances.
• A trial comparing the use of a fluoride-containing product versus
a non-fluoride control or an alternative fluoride product.
• A trial that assessed the prevalence or incidence of DLs either
at the start and at the end of orthodontic treatment or just at
the end of treatment, where the end was defined as the day of
removal of the fixed appliance or as soon as possible thereafter.
For studies that appeared to meet the inclusion criteria, or for
which data in the title and abstract were insufficient to allow a clear
decision, the full report was obtained. We resolved disagreements
by discussion.
No language restrictions were applied. Translations of foreign lan-
guage articles were produced by contacts within Cochrane Oral
Health.
Data extraction and management
Two review authors extracted data independently, in duplicate, us-
ing specially designed data extraction forms. The data extraction
forms were piloted on several papers and were modified as re-
quired before use. Any disagreement was discussed, and a third re-
view author was consulted when necessary. We contacted all study
authors for clarification of missing information. Data from studies
in which the reporting was incomplete were not included in the
analysis until the corresponding author of the study had supplied
adequate clarification. If agreement could not be reached, data
were excluded from the review. All studies that met the inclusion
criteria underwent an assessment of the risk of bias. We extracted
data from the published report; however if the report was unclear
or lacking in important information then the corresponding author
of the article was contacted by e-mail. We recorded studies reject-
ed at this or subsequent stages, along with reasons for exclusion, in
the 'Characteristics of excluded studies' tables.
For each trial, we recorded the following data.
• Year of publication and country of origin.
• Study design.
• Unit of randomisation.
• Details of participants, including demographic characteristics
and criteria for inclusion.
• Details of types of interventions (method of delivery of fluoride,
dose, duration of use).
• Details of outcomes reported (number, size and severity of DLs),
including method of assessment and mean duration of the
study.
Assessment of risk of bias in included studies
This assessment was conducted by using the recommended ap-
proach for assessing risk of bias in studies included in Cochrane
Reviews (Higgins 2011). We used the two-part tool to address the
six specific domains (namely, sequence generation, allocation con-
cealment, blinding, incomplete outcome data, selective outcome
reporting and other bias). Each domain includes one or more spe-
cific entries in a 'Risk of bias' table. Within each entry, the first part
of the tool involves describing what was reported to have happened
in the study. The second part of the tool involves assigning a judge-
ment relating to the risk of bias for that entry: either low risk, un-
clear risk or high risk.
The domains of sequence generation, allocation concealment, in-
complete outcome data and selective outcome reporting are ad-
dressed in the tool by a single entry for each study. For blinding, two
entries were used because assessments need to be made separate-
ly for (1) participants and operators/orthodontists and (2) outcome
assessors. When the operator/orthodontist assessed the outcome
of the trial, this was noted. The final domain ('other sources of bias')
was assessed as a single entry for studies as a whole.
Two review authors undertook the risk of bias assessment indepen-
dently and in duplicate as part of the data extraction process. We
resolved disagreements by discussion.
After taking into account additional information provided by the
authors of the trials, review authors grouped studies into the fol-
lowing categories.
 
Risk of bias Interpretation Within a study Across studies
Low risk of
bias
Plausible bias unlikely to seriously
alter the results
Low risk of bias for all key
domains




Plausible bias that raises some
doubt about the results
Unclear risk of bias for one
or more key domains
Most information comes from studies at low or
unclear risk of bias
High risk of
bias
Plausible bias that seriously weak-
ens confidence in the results
High risk of bias for one or
more key domains
The proportion of information from studies at
high risk of bias is sufficient to affect the inter-
pretation of results
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We completed a 'Risk of bias' table for each included study. We also
presented the results graphically (Figure 1).
 
Figure 1.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
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Measures of treatment e;ect
For dichotomous outcomes, we expressed the estimate of effect of
an intervention as risk ratios (RRs) together with 95% confidence
intervals (CIs). For continuous outcomes, we estimated mean dif-
ferences (MDs) and 95% CIs.
Unit of analysis issues
In parallel-group trials in which participants are randomly assigned
to intervention or to control and a single outcome measure per par-
ticipant is reported, the analysis is straightforward. When individu-
als are randomly assigned to treatment, each individual has a num-
ber of teeth exposed to the intervention or to the control. When the
outcome is reported per number of teeth, the data should be ad-
justed for clustering within the mouth of each individual to avoid
unit of analysis errors. If it was unclear from the reports of included
trials whether clustering had been considered, authors were con-
tacted to clarify how this dependence had been accounted for in
the analysis.
Dealing with missing data
When data were not available in the printed report, or when data
were unclear, we contacted the corresponding author of the study
to obtain the missing data. The analysis generally includes only
available data (ignoring missing data); we would, however, have
used methods of estimating missing standard deviations as pro-
vided in Section 7.7.3 of theCochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011), if appropriate. Otherwise, we
did not undertake any imputations or use statistical methods to al-
low for missing data.
Assessment of heterogeneity
Pooling of data and meta-analysis were carried out only if sufficient
similarities were noted between studies in types of participants, in-
terventions and outcomes, including the time of the outcome mea-
surement. If any trials were pooled, the significance of discrepan-
cies in the estimates of treatment effects from the different trials
was to be assessed by using Cochran's test for heterogeneity, by
which heterogeneity was considered significant if P < 0.1 (Higgins
2011).
The I2 statistic, which describes the percentage total variation
across studies that is due to heterogeneity rather than to chance,
was used to quantify heterogeneity, with I2 greater than 50% con-
sidered to show substantial heterogeneity (Higgins 2011: Section
9.5.2).
Assessment of reporting biases
Only a proportion of research projects conducted are ultimately
published in an indexed journal and become easily identifiable for
inclusion in systematic reviews.  Reporting biases arise when re-
porting of research findings is influenced by the nature and direc-
tion of the findings of the research. We investigated and attempt-
ed to minimise in this review potential reporting biases, including
publication bias, time lag bias, multiple (duplicate) publication bias
and language bias.
If more than ten studies were included for one outcome, we would
have constructed a funnel plot. Any asymmetry in the funnel plot
indicating possible publication bias would have been investigated
by statistical analysis using the methods introduced by Egger 1997
(continuous outcome) and Rücker 2008 (dichotomous outcome)
(such analysis would have been done in STATA 11.0). However, in-
sufficient trials were included in this review to enable the review
authors to investigate publication bias.
Data synthesis
A meta-analysis was to be conducted only if studies of similar com-
parisons reported the same outcome measures. Risk ratios would
have been combined for dichotomous data and mean differences
for continuous data, using random-effects models, provided more
than three studies were included in the meta-analysis.
Subgroup analysis and investigation of heterogeneity
We planned to investigate clinical heterogeneity by examining
the different sources of fluoride. Provided sufficient studies were
identified for each intervention and outcome, we planned a pri-
ori to conduct subgroup analyses for different sources of fluoride
(mouthrinse, gel, varnish dentifrice, bracket adhesive, elastomeric
ligature).
Sensitivity analysis
It was planned to undertake sensitivity analyses to examine the ef-
fects of quality assessment items on the assessment of overall es-
timates of effect. In addition, the effect on findings of the review of
including unpublished literature was to be examined. However, in-
sufficient trials were included in the review for a sensitivity analysis
to be undertaken.
Summary of findings
We developed 'Summary of findings' tables for the comparisons
that were considered most important for decision makers and the
outcomes number of participants with new DLs on the day the fixed
appliance was removed, number of participants with more severe
DLs, and number of participants with adverse effects using GRADE-
pro GDT software (GRADEpro GDT 2015). We assessed the level of
certainty in the findings with reference to the risk of bias assess-
ments, the directness of the evidence, the inconsistency of the re-
sults, the precision of the estimates, and the risk of publication bias.
The level of certainty for each of the comparisons was categorised
as high, moderate, low, or very low.
R E S U L T S
Description of studies
Results of the search
Searches were originally done in July 2003, then repeated in May
2012, January 2013, December 2016, January 2018 and February
2019.
The first version of this review included 14 trials, involving 613 par-
ticipants. The review protocol was amended for the 2013 update
to include only randomised studies (excluding quasi-randomised
or controlled clinical trials), using parallel groups and measur-
ing relevant outcomes over the full length of orthodontic treat-
ment. This resulted in the exclusion of all included studies from
the first version, for the following reasons: five were quasi-ran-
domised (Banks 2000; Dyer 1982; Hirschfield 1978; Millett 2000; So-
nis 1989), five were within-person or split-mouth designs (Chung
1998; Czochrowska 1998; Gillgrass 2001; Marcusson 1997; Twetman
1997) and three had ex vivo outcomes on extracted teeth (Gorton
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2003; Ogaard 1986; Pascotto 2004). Ogaard 2001 was excluded be-
cause investigators compared fluoride versus fluoride plus an anti-
septic solution.
The 2013 update included three studies (Luther 2005; Ogaard 2006;
Stecksén-Blicks 2007), involving 458 randomised participants (391
analysed). For the 2019 update a further seven studies were identi-
fied for inclusion (Benson 2019; He 2010; Jiang 2013; Jost-Brinkman
2017; Sonesson 2014; Sonesson 2019; van der Kaaij 2015). Three on-
going studies were also identified (DRKS00012533; DRKS00012540;
IRCT2016122531558N1).
For details of the studies examined and reasons for inclusion or ex-
clusion, please see Characteristics of included studies and Charac-
teristics of excluded studies tables. The search process and results
are presented as a flow chart in Figure 2.
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Figure 2.   Study flow diagram.
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Included studies
Characteristics of the trial participants and settings
Seven of the included studies were conducted in Europe, involv-
ing Sweden (Ogaard 2006; Sonesson 2014; Sonesson 2019; Steck-
sén-Blicks 2007), the UK (Luther 2005), the UK and Republic of Ire-
land (Benson 2019), and the Netherlands (van der Kaaij 2015). One
study was undertaken in Germany and Israel (Jost-Brinkman 2017)
and two in China (He 2010; Jiang 2013). Participant age ranged from
10 years at the start of treatment (Jost-Brinkman 2017) to 60 years
(Jost-Brinkman 2017). All participants in the included trials were re-
cruited at the start of their orthodontic treatment with fixed appli-
ances and were followed until their fixed appliances were removed.
Characteristics of the interventions
We have grouped the included trials into three broad comparisons.
• Dentist or nurse-applied fluoride in the form of varnish (He 2010;
Sonesson 2019; Stecksén-Blicks 2007), foam (Jiang 2013), and
gel (Jost-Brinkman 2017), both home use once a week and pro-
fessional application every three months.
• Patient-applied/used fluoride in the form of tooth-
paste/mouthrinse combinations (Ogaard 2006; Sonesson 2014;
van der Kaaij 2015).
• Fluoride-releasing materials in the form of intraoral fluoride-re-
leasing glass beads device (Luther 2005) and resin-modified
glass ionomer cement for bonding orthodontic brackets (Ben-
son 2019).
One study (Jost-Brinkman 2017) investigated both a dentist/nurse-
applied and a patient-applied fluoride intervention in the same par-
ticipants. Adherence to home use is more difficult to assess than
adherence to dentist or nurse-applied therefore it was categorised
in the latter. There were no studies investigating dietary fluoride
supplementation.
Five studies were placebo-controlled, comparing a fluoride-con-
taining product with the same product not containing fluoride,
where participant, clinician/operator and assessor were all masked
as to group allocation (Jiang 2013; Jost-Brinkman 2017; Sonesson
2019; Stecksén-Blicks 2007; van der Kaaij 2015). In four studies just
the assessor was masked for group allocation, due to differences in
the nature of the interventions. One study was a comparison of flu-
oride varnish versus placebo (He 2010). One study was a compari-
son of two products containing fluoride (Sonesson 2014), one was a
comparison of two methods of delivering fluoride (Luther 2005) and
one study compared one fluoride and one non-fluoride containing
bonding material (Benson 2019). One study compared two fluoride
products, but the masking was unclear (Ogaard 2006).
Characteristics of the outcomes
Seven studies reported our primary outcome of number of partici-
pants in each group with new demineralised lesions (DLs) (Benson
2019; Jost-Brinkman 2017; Luther 2005; Sonesson 2014; Sonesson
2019; Stecksén-Blicks 2007; van der Kaaij 2015). One study reported
the number of teeth in each group with new DLs (Jiang 2013), one
study reported a mean index score (Ogaard 2006), and in one study
the outcome was unclear (He 2010).
All reported some outcomes on the severity of DLs in terms of dif-
ferences in the number, size, colour, or quantitative measurement
of mineral loss. None of the included studies reported outcomes of
participant perception of their DLs or oral health-related quality of
life, and only one study reported adverse effects (Sonesson 2019).
Excluded studies
The details and reasons for exclusion are outlined in the Charac-
teristics of excluded studies table. The main reasons for exclusion
were that participants were not followed to the end of their ortho-
dontic treatment and an inappropriate research methodology was
used (within-person or split-mouth design).
Risk of bias in included studies
Overall risk of bias assessments for all included studies are shown
in Figure 1. Two studies were assessed at low risk of bias for all do-
mains (Sonesson 2019; Stecksén-Blicks 2007). Two studies were as-
sessed as at unclear risk of bias in one or two domains (Benson
2019; Sonesson 2014) and four in more than two domains (He 2010;
Jiang 2013; Jost-Brinkman 2017; Ogaard 2006). Two studies were
assessed as at high risk of bias in one domain (Luther 2005; van der
Kaaij 2015) due to a high proportion of participants withdrawing or
dropping out of the studies. The authors of the studies have been
contacted for further information, but at the time of publication
we are awaiting clarification from the authors of two studies (Jost-
Brinkman 2017; Ogaard 2006) and one is currently uncontactable
(He 2010).
Allocation
We assessed six of the included studies at low risk of bias, because
the method of sequence generation and clear allocation conceal-
ment were considered adequate from either the description in the
reported or following further clarification from the study authors
(Benson 2019; Luther 2005; Sonesson 2014; Sonesson 2019; Steck-
sen-Blicks 2007; van der Kaaij 2015).
Three studies (He 2010; Jiang 2013; Ogaard 2006) reported the
method of sequence generation (randomisation table), but did not
mention how they achieved equal numbers of participants in each
group (since clarified for Jiang 2013) or method of allocation con-
cealment. One study described the method of allocation conceal-
ment, but did not report the method of sequence generation (Jost-
Brinkman 2017). They were all assessed as at unclear risk of selec-
tion bias.
Blinding
In five studies the participant, clinician and assessor were all con-
sidered masked to group allocation, because the authors reported
that the substances provided to the active and control groups were
identical in presentation, taste, appearance and consistency (Jiang
2013; Jost-Brinkman 2017; Sonesson 2019; Stecksén-Blicks 2007;
van der Kaaij 2015). Due to the nature of the materials used in three
studies it was not possible to mask the clinician as to group alloca-
tion and the participant could have guessed (Benson 2019; Luther
2005; Sonesson 2014). It is not clear how knowledge of group allo-
cation might affect the behaviour of the clinician and participant,
so these were judged to be an unclear risk of performance bias. In
one study the masking was not clear (Ogaard 2006) and the author
has been contacted. In one study, the participants received differ-
ent preventative regimens, at different times, therefore neither par-
ticipants or operators could be masked (He 2010).
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Nine studies reported that the outcome assessors were masked
as to group allocation. In four of these studies more than one ex-
pert judge was involved in assessing before treatment and day of
debond or close to debond photographs for new DLs (Benson 2019;
Sonesson 2014; Sonesson 2019; Stecksén-Blicks 2007). In two stud-
ies only one assessor was involved, but using relatively objective
measures of demineralisation (image analysis (Luther 2005), and
quantitative light-induced fluorescence (QLF) (van der Kaaij 2015)).
These were judged to be at low risk of detection bias.
We are still awaiting clarification from Jost-Brinkman 2017 about
who and how many undertook the clinical assessments, whether
they were calibrated and whether any assessment of reproducibil-
ity was undertaken.
Jiang 2013 reported that assessments were undertaken clinically
by one masked assessor. Although the assessor was described as
having participated in the 'initial calibration trial' and intraexam-
iner agreement was assessed before the start of the trial, it is not
clear if the repeatability was good for the full length of the trial and
whether the assessor agreed with other calibrated assessors. This
study was therefore assessed to be an unclear risk of detection bias.
Ogaard 2006 indicates that clinical assessments and colour pho-
tographs were obtained prior to bonding and at debond, but does
not state that the photographs were used in the assessment. There
are no details about who carried out the assessments or whether
they were calibrated. No repeatability or reproducibility assess-
ments are reported and this study was therefore judged to be an
unclear risk of detection bias.
In He 2010 the number of assessors was unclear. It was also judged
to be an unclear risk of detection bias.
Incomplete outcome data
The proportion of post-randomisation exclusions was reported as
zero in one study (He 2010), and low in four studies (Benson 2019;
Jiang 2013; Sonesson 2019; Stecksén-Blicks 2007). The numbers
and reasons for exclusion were similar for each group and the risk
of attrition bias and the effect of this on the interpretation of the
findings is outlined in the 'Risk of bias' tables for each study. The re-
port by Benson 2019 had a flow diagram and fully reported the rea-
sons for withdrawal or dropout, which were about equal in the two
groups. Two studies were assessed as an unclear risk of attrition
bias (Ogaard 2006; Sonesson 2014). The reasons for this are given
in the 'Risk of bias' tables for each study. The report by Ogaard 2006
had neither a flow diagram, nor a detailed explanation of the rea-
sons for withdrawal or dropout. Sonesson 2014 had a flow diagram
and reported the reasons for withdrawal or dropout, however it re-
ports that a number of participants "did not comply with the study
protocol" and were excluded from the analysis, but the definition
of non-compliance is unclear. Due to inconsistencies on the num-
ber of exclusions from analyses and lack of clarity on non-compli-
ance Jost-Brinkman 2017 was also assessed as at unclear risk of at-
trition bias. Two studies were assessed as at high risk of attrition
bias, because a significant proportion of the participants who were
randomised were not included in the analysis (47% (Luther 2005),
33% (van der Kaaij 2015)).
Selective reporting
Ogaard 2006 reported the change in the mean Gorelick Index
scores, as well as the numbers of teeth with new DLs and was as-
sessed as at unclear risk of reporting bias. The report by Luther 2005
had some information missing and the denominators were not stat-
ed, so this study was assessed at unclear risk of reporting bias. In
He 2010 the definition of incidence is unclear (difference between
start and finish) and it does not state how they took into account
the clustering of teeth within the mouth, therefore the study was
also assessed at unclear risk of reporting bias.
Other potential sources of bias
Four studies reported data for the number of participants with new
DLs at or near the date of debond (Benson 2019; Sonesson 2014;
Sonesson 2019; Stecksén-Blicks 2007). All these studies assessed
the number of new DLs (incidence) by comparing pre-treatment
and at or near debond photographs and were considered to be at
low risk of other potential sources of bias. Other potential sources
of bias are discussed for these studies, but they were assessed at
low potential risk of bias, as was the study by Ogaard 2006. Luther
2005 was assessed at unclear risk of other bias, because of possible
differences between the groups in terms of compliance, duration
of orthodontic treatment and exposure to topical fluorides. van der
Kaaij 2015 was also assessed as at unclear risk of bias, because it is
unclear if all the QLF images were collected and analysed from the
day of debond. The authors state that the "WSL assessments were
made at an average of 52 d (days) after debonding (with a range
of 0-156 d)." Those undertaken at five months following debond
might have undergone quite extensive remineralisation unrelated
to mouthrinse use. Jiang 2013 was also assessed as unclear risk of
bias in this domain, because it was not clear from the report how
many operators were involved in the study and how the investiga-
tors controlled for other sources of fluoride. We are still awaiting
clarification about other sources of bias from Jost-Brinkman 2017
and were not able to contact the authors of He 2010.
E;ects of interventions
See: Summary of findings for the main comparison Den-
tist/nurse-applied fluoride: fluoride varnish compared to non-flu-
oride (placebo) varnish for preventing early tooth decay (deminer-
alised lesions) during fixed brace treatment; Summary of find-
ings 2 Dentist/nurse-applied fluoride: 12,300 ppm F APF foam com-
pared to 0 ppm F placebo foam for preventing early tooth de-
cay (demineralised lesions) during fixed brace treatment; Summa-
ry of findings 3 Patient-applied/used fluoride: 5000 ppm F tooth-
paste compared to 1450 ppm F toothpaste for preventing early
tooth decay (demineralised lesions) during fixed brace treatment;
Summary of findings 4 Patient-applied/used fluoride: 250 ppm
F mouthrinse (100 ppm F amine F/150 ppm NaF) compared to 0
ppm F placebo mouthrinse for preventing early tooth decay (dem-
ineralised lesions) during fixed brace treatment; Summary of find-
ings 5 Fluoride-releasing materials: resin-modified glass ionomer
cement compared to light-cured composite resin for bonding or-
thodontic brackets for preventing early tooth decay (demineralised
lesions) during fixed brace treatment
The 10 studies included in this review evaluated different modes of
fluoride application, which we have categorised into three broad
methods.
• Professionally-applied (dentist or nurse-applied) fluoride in the
form of varnish (He 2010; Sonesson 2019; Stecksén-Blicks 2007),
foam (Jiang 2013) and gel (Jost-Brinkman 2017), both home use
once a week and professional application every three months.
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• Patient-applied/used fluoride in the form of tooth-
paste/mouthrinse combinations (Ogaard 2006; Sonesson 2014;
van der Kaaij 2015).
• Fluoride-releasing materials in the form of intraoral fluoride-re-
leasing glass bead device (Luther 2005) and resin-modified glass
ionomer cement for bonding orthodontic brackets (Benson
2019).
Although the study by Jost-Brinkman and colleagues (Jost-
Brinkman 2017) investigated both a dentist/nurse-applied and a
patient-applied fluoride intervention in the same participants, we
have placed this in the dentist or nurse-applied category for the
reasons explained previously. Summaries of the methods, partici-
pants, interventions and outcomes for each study are provided in
the Characteristics of included studies tables.
Dentist or nurse-applied fluoride
Primary outcome
Stecksén-Blicks 2007 reported a prevalence of DLs before treat-
ment of 4.3% in participants who received the professionally-ap-
plied fluoride varnish (experimental group) and 4.0% in those re-
ceiving the professionally-applied non–fluoride placebo varnish
(control group). At debond the proportions of participants with
DLs was 11.7% in the experimental group and 29.7% in the control
group, which the authors state as an incidence of 7.4% and 25.7%
respectively. The authors report a risk reduction or preventive frac-
tion (1-RR) of 0.69 for new DLs. The authors calculated that nearly
6 (5.5) individuals would need to receive the fluoride varnish every
orthodontic visit (approximately every six weeks) to prevent one
patient from having a new DL (number needed to treat or NNT).
This result should be treated with caution, because another trial
by Sonesson and colleagues (Sonesson 2019) using a slightly lower
concentration of fluoride varnish (7000 parts per million (ppm) flu-
oride) had different findings. They reported a prevalence of DLs be-
fore treatment of 8.0% (6 out of 75) in participants who received the
professionally-applied fluoride varnish (experimental group) and
9.6% (7 out of 73) in those receiving the professionally-applied non-
fluoride placebo varnish (control group). At debond the propor-
tions of participants with DLs (index scores of 2 and above) was
41.3% (31 out of 75) in the experimental group and 43.8% (32 out
of 73) in the control group. Combining the data from these two
studies the calculated risk ratio (RR) for the development of new
lesions with professionally-applied fluoride varnish was 0.52 (95%
confidence interval (CI) 0.14 to 1.93; 405 participants; Analysis 1.1),
which is a non-significant reduction.
Jost-Brinkman 2017, who applied fluoride gel every three months
(as well as home-used gel), found no difference in the development
of DLs between those who were allocated to the fluoride gel and
those to the placebo gel (RR 0.99, 95% CI 0.76 to 1.27; 312 partici-
pants; Analysis 2.1).
Jiang 2013 found that applying a fluoride-containing foam profes-
sionally every two months reduces the incidence of new DLs after
fixed orthodontic treatment (RR 0.26, 95% CI 0.11 to 0.57; 95 partic-
ipants analysed; Analysis 3.1).
As previously stated we were not able to contact the authors of He
2010.
Secondary outcomes
Stecksén-Blicks 2007 stated that they calculated a "progression
score" by "subtracting the debond score from that registered at
baseline." The progression scores were mean 0.8 (standard devia-
tion (SD) 2.0) for participants who received the fluoride varnish and
mean 2.6 (SD 2.8) for those who received the placebo varnish. We
interpret this as the control group having a greater number of teeth
with lesions, as well as a greater incidence. In terms of severity Fig-
ure 2 in the study shows that the great majority of new lesions were
minor (Gorelick Index score 2: slight white spot formation, thin rim)
and the aesthetic impact of the new DLs was not assessed.
Sonesson 2019 reported a reduction in the number of participants
with the more severe DLs (index score of 3 or 4) at debond in the
experimental group who received the fluoride varnish (12%, 9 out
of 75), compared with the non-fluoride control (26%, 19 out of 73).
This is a RR of 0.46 (95% CI 0.22 to 0.95) and a number needed to
treat of 7 (but with a wide confidence interval 3.80 to 71.10).
Jiang 2013 reported that the "mean net increment" in the scores
was 0.7 (SD 2.8) for those who received the fluoride foam and 4.4
(SD 5.4) for those who received the non-fluoride foam. This is a
large increase, which we interpret as those not receiving the fluo-
ride foam having a greater number of teeth affected by DLs. The au-
thors cite a NNT, but we believe this is calculated on the number
of teeth with new DLs, not participants, which is not appropriate.
Again, the severity scores (Figure 2) were mostly minor (Gorelick In-
dex 2) and the aesthetic impact is uncertain.
There were no data reported from any of the studies about partic-
ipant perception of their DLs or any measure of oral health-relat-
ed quality of life. Only Sonesson 2019 reported adverse effects and
that one participant who received the fluoride varnish withdrew
from their study, due to a feeling of slight nausea during the trial.
Patient-applied/used various fluoride toothpaste/mouthrinse
combinations
Primary outcome
Sonesson 2014 found that the proportions of participants with DLs
before orthodontic treatment were 17% in the high concentration
fluoride (5000 ppm) toothpaste group and 19% in the standard con-
centration fluoride (1450 ppm) toothpaste group. These propor-
tions increased to 35% and 45% respectively, on the day of debond.
The calculated RR of developing a new DL is 0.68 (95% CI 0.46 to
1.00; 380 participants; Analysis 4.1). Although the upper confidence
interval contacts the line of no difference, we believe that this pro-
vides evidence that the use of high fluoride toothpaste by patients
wearing fixed orthodontic appliances does provide some protec-
tion against new DLs, with a risk reduction or preventive fraction
(1-RR) of 0.32 and a NNT of 12. As with the trial by Stecksén-Blicks
2007, however, the results of this trial should be interpreted with
caution until further clinical trials confirm this finding.
van der Kaaij 2015 states that none of their participants had DLs be-
fore the start of treatment. They report that 11 of 36 participants
in the fluoride mouthrinse group developed at least one new DL,
compared with 21 of 45 participants in the non-fluoride mouthrinse
group. However, the calculated RR is 0.65 (95% CI 0.37 to 1.17; 81
participants; Analysis 5.1) and the confidence interval crosses the
line of no difference. The lack of statistical significance could be
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due to the small number of participants and the large proportion of
withdrawals and dropouts.
Ogaard 2006 reported the outcome of new DLs at the tooth level
with no indication of correction for clustering of teeth within the
mouth. The author has been contacted to provide these data at the
participant level.
Secondary outcomes
Sonesson 2014 reported that the mean numbers of DLs before the
start of treatment were 0.3 (SD 1.0) in the high concentration flu-
oride (5000 ppm) toothpaste group and 1.0 (SD 1.8) in the stan-
dard concentration fluoride (1450 ppm) toothpaste group. These
increased to 0.4 (SD 1.0) and 1.2 (SD 1.8) respectively, at debond.
They also stated that the "vast majority of all new WSL were thin
rims (score 2) in both groups," with only 1.2% in the high fluoride
toothpaste group and 2.3% in the standard fluoride toothpaste
group having teeth affected with the more severe Gorelick Index
scores of 3 or 4. The aesthetic impact of the DLs is, therefore, un-
clear. Like most studies they report that lateral incisors were the
most frequently affected teeth in both groups, followed by the ca-
nines and premolars.
van der Kaaij 2015 reported that the number of new DLs ranged
from 1 to 5 in participants who received the fluoride mouthrinse
(experimental group) and 1 to 15 in those receiving the non-fluo-
ride mouthrinse (control group). The quantitative light-induced flu-
orescence (QLF) measurements revealed a mean fluorescence loss
(delta F; DL – sound enamel) of 11.6% (SD 5.0) in the experimental
group and 10.3% (SD 3.0) in the control group. The lesion depths
were 0.9 mm2 (SD 0.6) and 1.3 mm2 (SD 1.6 mm) respectively. Nei-
ther were reported as statistically significant and there is no indica-
tion in the report how these QLF measurements can be interpreted
in terms of aesthetic impact.
Ogaard 2006 found a greater mean change in the 'white spot lesion
index' from baseline in a group of participants using a neutral sodi-
um fluoride toothpaste (1400 ppm, pH 6.7) twice daily and a sodi-
um fluoride mouthrinse (250 ppm fluoride (F), pH 6.3) at night com-
pared with a group using amine fluoride/stannous fluoride tooth-
paste (Meridol 140 ppm F, pH 4.5) twice daily and an amine fluo-
ride/stannous fluoride mouthrinse (250 ppm F, pH 4.0) after tooth-
brushing at bedtime (97 participants; Analysis 6.1). This suggest
that the sodium fluoride combination was less effective than the
amine fluoride/stannous fluoride. They also found a slightly larg-
er increase in both the visible plaque index and the gingival bleed-
ing index over the duration of treatment in the group exposed to
sodium fluoride (97 participants; Analysis 6.2; Analysis 6.3). These
differences, however, should be interpreted cautiously until the re-
sults can be independently replicated.
There were no data reported from any of the studies about partic-
ipant perception of their DLs, any measure of oral health-related
quality of life, and/or reports of adverse effects.
Fluoride-releasing materials
Primary outcome
Benson 2019 did not assess the number of DLs at baseline, rather
the assessors were asked to look concurrently at the before treat-
ment and day of debond images and determine if they saw new
DLs. On this basis 23 out of 88 participants who received the flu-
oride-containing bonding material (resin-modified glass ionomer
cement) were assessed as having new DLs versus 19 out of 85 who
received the material containing no fluoride (light-cured composite
resin). The calculated RR was 1.17 (95% CI 0.69 to 1.99; 173 partici-
pants; Analysis 7.1); therefore, there was no difference statistically
or clinically in the proportion of participants with new DLs between
the two groups.
Luther 2005 reported that, of those participants completing the
trial, 10 of the 18 receiving the fluoride-containing glass beads
developed DLs, compared with 7 out 19 receiving the fluoride
mouthrinse. The calculated RR was 1.51 (95% CI 0.73 to 3.10; 37 par-
ticipants; Analysis 8.1), which is not statistically significant.
Secondary outcomes
Unlike any of the other studies, Benson 2019 undertook an assess-
ment of the aesthetic impact of the new DLs. They found that in only
15 of the 42 participants with new DLs were the lesions judged to be
of aesthetic concern by a majority of the expert and lay assessors.
Therefore, the incidence of aesthetically displeasing new DLs was
9% compared with the overall incidence of 24% and there was no
difference between the groups (fluoride material 8 out of 23; non-
fluoride material 7 out of 19). Like other studies they found that up-
per lateral incisors were affected most, followed by upper central
incisors and upper canines. This study also reported the proportion
of bond failures, which was not an outcome in this review.
Luther 2005 reported that, for those participants who completed
their trial, there was no statistically significant difference in the
numbers of teeth affected by DLs between the two groups (fluo-
ride-releasing beads 17 out of 108 teeth; fluoride mouthrinse 19 out
of 114).
There were no data reported from any of the studies about adverse
effects, participant perception of their DLs and/or any measures of
oral health-related quality of life.
D I S C U S S I O N
Summary of main results
There is insufficient evidence of a difference from two trials, judged
to be at a low risk of bias, on the effectiveness of fluoride varnish
applied, by a professional, every six weeks in reducing new dem-
ineralised lesions (DLs) during fixed orthodontic treatment (Sum-
mary of findings for the main comparison). Evidence from one trial
judged to be at unclear risk of bias, provides a low level of certainty
that fluoride foam (12,300 parts per million (ppm) fluoride), profes-
sionally applied every two months, reduces the incidence of new
DLs after fixed orthodontic treatment (Summary of findings 2). Sim-
ilarly, one trial, assessed as at unclear risk of bias, provides a low
level of certainty that use of a high-concentration fluoride tooth-
paste by patients throughout their fixed orthodontic treatment re-
duces the incidence of new DLs, compared with a conventional
concentration of fluoride toothpaste (Summary of findings 3).
Evidence is insufficient to show whether the use of a profession-
ally-applied amine fluoride gel reduces new DLs (Additional Table
1), or patient use of a sodium fluoride/amine fluoride mouthrinse
(Summary of findings 4) or amine fluoride and stannous fluo-
ride toothpaste/mouthrinse combination (Additional Table 2) is
more or less effective than a non-fluoride mouthrinse or a sodi-
um fluoride toothpaste/mouthrinse combination respectively. Fi-
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nally, there is no evidence that either a fluoride-containing mate-
rial to bond brackets (Summary of findings 5) or an intraoral fluo-
ride-releasing glass bead device (Additional Table 3) reduces the
incidence of new DLs.
Overall completeness and applicability of evidence
As with the last version, the update of this review has included only
parallel-group trials, in which the individual participant is the unit
of randomisation. This was decided upon because of the possibili-
ty of cross-contamination between experimental and control teeth
in the same mouth, either between upper and lower arches or be-
tween sides of the mouth, which might lead to under-estimation of
the effectiveness of any fluoride products.
Interventions that rely on the patient for delivery, including fluoride
mouthrinse and toothpaste, will work only if they are used regular-
ly. They rely greatly on patient compliance to succeed; however, ev-
idence suggests that compliance with mouthrinsing is poor among
orthodontic patients. One study (Geiger 1992) found that only 42%
of participants rinsed with a sodium fluoride mouthrinse at least
every other day. Results also showed that those who complied least
with fluoride rinsing regimens tended to have more DLs. It is im-
portant to consider the acceptability of interventions to both ado-
lescents and adults with a view toward increasing compliance with
recommended dental hygiene practices.
Interventions that are professionally applied and deliver fluoride
'passively', such as fluoride varnish, fluoride-releasing bracket ce-
ments and fluoride-releasing elastics, avoid the need for patient
compliance. In addition, these materials deliver fluoride close to
the bracket, where it is most needed. Many fluoridated materials
release large amounts of fluoride initially, but the level drops rapid-
ly and might not be sufficient to prevent decay over the whole
course of orthodontic treatment. Reapplication of fluoride varnish
and frequent replacement of fluoride-releasing elastics are likely
to be required. In the parallel-group trial of a fluoride varnish in-
tervention included in this review, varnish was reapplied every six
weeks at each orthodontic check-up appointment. We found no
parallel-group trials of fluoride-releasing cements or elastics that
met the inclusion criteria for this review.
An interesting addition, since the initial review was carried out, is
the further development of materials that produce a slow and sus-
tained release of fluoride (Luther 2005). This trial was small and at
high risk of bias, and evidence was insufficient to reveal whether
these devices are more or less effective than a mouthrinse in reduc-
ing the development of DLs. It is possible, that with further refine-
ment, this technique could potentially be effective. Intraoral fluo-
ride-releasing devices should be evaluated by parallel-group ran-
domised controlled trials with appropriate masking of participants,
clinicians/operators and assessors.
When examining the effectiveness of a fluoride product in prevent-
ing dental decay, one should consider two aspects: first, whether
the fluoride product reduces the number of DLs appearing during
treatment, and second, whether it reduces the severity of DLs in
terms of the size or area of the tooth surface affected, the amount
of mineral lost or the depth of decay. Banks et al (Banks 2000) de-
veloped the Enamel Decalcification Index, which is an ordinal index
that includes an assessment of the area covered. Assessment of the
size of the lesion is a useful outcome measure, but none of the stud-
ies included in this review reported this outcome.
Ideally the appearance of the tooth should be recorded before
and after orthodontic treatment, so that the change in appearance
of the tooth is measured (incidence), not just its appearance at
the end (prevalence). There are many different causes of coloured
marks on the teeth, many of which occur during their development.
It is important that these development lesions, as well as decay that
has occurred before the brace is fitted, are excluded from the analy-
sis, hence the need for the clinical photographs or fluorescent im-
ages taken before treatment. Measurement of both incidence and
severity will depend on the method used to record DLs. Two main
methods may be used: visual inspection and clinical images. Both
methods are associated with problems. One problem with visual in-
spection is that the examiner or examiners will require calibration
at the start and regular recalibration throughout the experimental
period to ensure consistency of measurement. The duration of the
experiment, including the recruitment and data collection will be
long because, as discussed later, the product should be tested over
the entire length of orthodontic treatment. This can take between
18 and 30 months - sometimes longer. Another problem with visu-
al recording clinically involves masking of the assessor to the allo-
cated intervention. To reduce bias, the examiner should not know
whether the participant has received a fluoride product and this
will complicate the way the experiment is run.
Images have the advantage of providing a permanent record of the
appearance of the tooth. Assessments can be carried out by sev-
eral people independently or in groups, whereby a consensus is
achieved. The images can be placed in a random order and the
judges masked to group allocation. In addition, because the assess-
ment can be performed over a short period of time the problem of
examiner driJ, whereby an assessor might subtly change his or her
assessment over time, is reduced. The challenge of using clinical
photographs consists of achieving consistency in lighting and re-
ducing reflections that can mask or mimic DLs. When a careful pho-
tographic technique is applied, however, the advantages of pho-
tographs outweigh their potential disadvantages. Several optical
and fluorescent methods are available for measuring lesions on the
teeth (Angmar-Mansson 1996). These methods require specialised
equipment, which would add considerably to the cost of a clinical
study, but they provide an objective measurement of the amount
of decay in terms of mineral loss or lesion depth or both.
Quality of the evidence
Two studies included in this review were judged to be at low risk of
bias in all domains; however clarification over some issues was re-
quired from some of the authors before these judgements could be
confirmed. Both the design and the reporting of trials of fluorides
for preventing DLs have improved since the first version of this re-
view and we hope that this may continue. Undoubtedly the increas-
ing use of the CONSORT guidelines for the reporting of randomised
controlled trials has been a factor.
Several of the studies were assessed at some risk of bias as a result
of the proportion of participants randomised to the intervention
not been included in the analysis following withdrawal or dropout.
It is inevitable that some patients will move away during a course of
orthodontic treatment, but every effort should be made to collect
records and data at the appropriate times, even if the treatment is
finished early.
Another issue in orthodontic research is that it is often not possi-
ble to mask the clinician/operator to the allocated intervention. In
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these situations the participant can also usually work out to which
group they have been allocated and, therefore, triple-blinding is
difficult, if not impossible to achieve. It is, however, not clear how
much this will affect the behaviour of the clinician and the partici-
pant. It is known that patients respond favourably to simply being
part of a clinical trial, irrespective of whether they have received
the active intervention or the control (McCarney 2007). This is the
so-called Hawthorne effect, named after a Chicago electrical com-
pany works, whose workers were subjected to a series of experi-
ments during the 1920s and 1930s. The investigators noticed that
no matter how they changed the working conditions of the work-
ers their productivity improved and concluded it was because they
knew they were part of an experiment. We believe that it would be
harsh to judge all trials that are not triple-blind as a potentially high
risk of bias when the effects are not known and perhaps this should
be an area of research in the future.
Potential biases in the review process
We undertook a sensitive search of several electronic sources, sup-
plemented by searches of references lists. We placed no restriction
on language or publication status. The review authors have tried, as
far as possible, to identify all possible studies that might meet the
inclusion criteria for this review. Study authors have been contact-
ed, and many have replied; however, some were not able to supply
the requested information, as their records have been destroyed or
lost.
When a product, such as a bonding material, can be applied to sin-
gle teeth, it is tempting to use an experimental design whereby the
material being tested is used in two quadrants of the mouth and the
control material is used in the other two quadrants. This is called
a split-mouth design. The main advantage of the split-mouth de-
sign over a conventional parallel-group study design, in which the
two materials are tested in two separate groups of individuals, is
that the experimental material is tested in the same mouth, under
the same conditions as the control material. In theory, any differ-
ences in outcome between the two materials are due only to their
properties - not to other factors, such as differences in oral hygiene
and diet between participants (with a parallel design) or even dif-
ferences in oral hygiene and diet over time within the same partic-
ipants (with a cross-over design).
Unfortunately, when one is examining the ability of fluoride prod-
ucts to reduce decay, it is highly unlikely that the fluoride released
will be confined to only the quadrants/teeth in which the experi-
mental material has been placed, and some contamination of the
'untreated' teeth is inevitable. This contamination will reduce the
difference in outcomes between treated and untreated teeth. The
previous version of this review included split-mouth studies, which
failed to show any difference between treated and untreated teeth;
this may be due to cross-over contamination between control and
experimental sides and may reflect our contention of contamina-
tion. For this reason, we have decided to exclude split-mouth stud-
ies from the previous update of our review.
Agreements and disagreements with other studies or
reviews
Three other systematic reviews gathering evidence for the most ef-
fective means of preventing caries/demineralisation during fixed
orthodontic appliance treatment have been reported in the liter-
ature. Derks et al (Derks 2004) examined all preventive measures
for preventing demineralisation - not just fluoride products. These
review authors had to exclude many published studies as well, be-
cause of inappropriate research design or poor reporting and were
unable to provide firm, evidence-based recommendations as to the
prevention of DLs during fixed orthodontic treatment.
A second systematic review (Chadwick 2005) investigated the effec-
tiveness of topical fluorides used alone in preventing demineralisa-
tion during orthodontic treatment. These review authors included
seven studies in their review; these studies, however, were exclud-
ed from our review, because the outcomes were not appropriate
(DMFT/DMFS (decayed, missing, and filled teeth/surfaces)), or the
participants were not examined immediately after removal of the
fixed appliance(s). Although they suggest that according to their
outcome measure (preventive fraction), some evidence shows that
the addition of a topical fluoride preparation helps in the preven-
tion of demineralisation during fixed orthodontic treatment, this
conclusion must be viewed with caution, because these review au-
thors were not able to calculate confidence intervals. We support
their request that researchers design and report their studies using
standard outcomes, so that in the future, data may be pooled and
overall recommendations on preventive measures may be provid-
ed.
Rogers et al (Rogers 2010) included 10 studies in their systematic re-
view investigating the effectiveness of fluoride-containing bonding
adhesives used in orthodontics to prevent demineralisation. Five
of these studies were excluded from our review because they were
not randomised, and a further three studies were excluded because
data in the report were insufficient, and the study authors, when
contacted, were unable to provide requested data. Rogers' conclu-
sions are consistent with ours with regard to the design of trials and
the quality of reporting and statistical analyses.
Wang 2013 included 20 studies (19 articles) in their review, which
is written in Chinese and only includes data from Chinese studies.
They included studies with quasi-randomised designs and it is not
clear if they included studies with a within-person (split-mouth) de-
sign and those not following patients for the full length of ortho-
dontic treatment.
The following reviews were also examined: Höchli 2017; Lapenaite
2016; Lopatiene 2016; Nascimento 2016; Rahimi 2017; Sardana
2019a; Sardana 2019b; Tasios 2019. These reviews either investigat-
ed interventions other than fluoride to prevent DLs, such as casein
phosphopeptide-amorphous calcium phosphate (CCP-ACP), treat-
ment of DLs after the appliance was removed or included quasi-
and non-randomised studies, studies with short follow-up or out-
comes that are not particularly relevant to patients and clinicians.
No new studies were identified from the references in these articles
to include in this review.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
There was insufficient evidence of a difference from two clinical tri-
als that professional application of fluoride varnish (7700 or 10,000
parts per million (ppm) fluoride) every six weeks to the teeth of pa-
tients wearing fixed orthodontic braces reduces the number of new
demineralised lesions (DLs).
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One study provides a low level of certainty that a 12,300 ppm flu-
oride foam professionally applied every two months, reduces the
incidence of new DLs after fixed orthodontic treatment.
Evidence for the use of fluoride products at home by patients in-
cludes one trial, providing a low level of certainty that a high flu-
oride (5000 ppm) toothpaste used throughout orthodontic treat-
ment with fixed appliances might reduce the number of patients
with new DLs, compared to a conventional fluoride toothpaste.
Evidence is insufficient for review authors to recommend the use
of fluoride-containing materials to attached braces to the teeth or
intraoral fluoride-releasing devices. Such interventions, provided
they sustain the release of fluoride, have the potential to be effec-
tive, as they reduce the requirement for patient adherence to their
use.
The use of fluoride mouthrinses by patients/participants, in addi-
tion to fluoride toothpastes, has been found to be effective in re-
ducing caries in non-orthodontic patients. No direct evidence, how-
ever, from this review indicates that this combination of fluoride
delivery is effective in reducing DLs during fixed orthodontic appli-
ance treatment.
Implications for research
More evidence is required before the most effective way of deliver-
ing fluoride to the orthodontic patient can be determined with con-
fidence. In particular, fluoride delivery methods that do not require
patient adherence should be studied. Adequately powered, appro-
priately masked, placebo-controlled trials, with suitable randomi-
sation, allocation concealment and masking of outcome assess-
ment, are needed. A placebo-only group, however, may be consid-
ered unethical. The use of factorial designs, whereby two or more
experimental interventions are evaluated simultaneously allowing
for the evaluation of possible interaction between the interven-
tions, can be evaluated separately. Researchers should, however,
be aware that increasing the number of arms in a trial will substan-
tially increase the number of participants required to demonstrate
a statistical difference between interventions.
The use of images to record the condition of the tooth before and af-
ter treatment should be encouraged. Images provide a permanent
record, allowing before and after comparisons of the incidence and
severity of DLs with proper assessor masking, error analysis and
consensus measures. To provide a reproducible method of record-
ing DLs using photographs, a standard technique is required, with
thought given to reduction of flash reflection, magnification and
drying of the teeth. Optical and fluorescent methods of providing a
quantitative measurement of mineral loss might be useful if fund-
ing allows, but it is important that outcomes are clinically relevant
and meaningful to patients and clinicians.
Finally, we would encourage researchers in this area to use more
than one assessor when determining the presence or absence of
new DLs. The assessment is to a certain extent subjective, open
to interpretation and may lead to detection bias if only one opin-
ion is obtained. We would also suggest that an assessment of the
aesthetic impact of the DLs should be made. Some DLs, although
present, are small, barely noticeable and will probably remineralise
with time. Although every effort should be made to prevent these
lesions from forming, their impact on the individual and the long-
term health of the dentition will probably be minimal. Studies ide-
ally should assess patient-centred outcomes, including the effect
of DLs on quality of life, particularly six months or a year after treat-
ment.
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Characteristics of included studies [ordered by study ID]
 
Methods Design: multicentre, randomised controlled trial, assessing superiority with 2 parallel groups
Unit of randomisation: participant, stratified on operator
Setting: 6 centres, 2 dental teaching hospitals and 4 specialist orthodontic practices, UK and Republic
of Ireland
Recruiting period: February 2009 to March 2012
Participants Inclusion criteria: 11 years and older; full permanent dentition, requiring upper and lower fixed appli-
ances; in good general health; oral hygiene was considered by the operator to be sufficient for fixed ap-
pliance treatment
Exclusion criteria: patients with a cleJ of the lip and/or palate; or who require orthognathic surgery
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Mean age at baseline, years: 15.5 years (SD 3.3 years, range 11 to 34)
Number randomised: 210 (109 LCC, 101 RM-GIC)
Number evaluated: 173 (88 LCC, 85 RM-GIC)
Duration of treatment: 17.6 SD 7.1 months (17.3 SD 7.3 months RM-GIC, 17.9 SD 7.0 months LCC)
Interventions Comparison: resin-modified glass ionomer cement (RM-GIC - GC Fuji ORTHO™ LC, GC Corp, Tokyo,
Japan) versus light-cured composite resin (LCC - Transbond™ XT Light Cure Adhesive, 3M Unitek,
Diegem, Belgium) for bonding orthodontic brackets
Outcomes Primary outcome: presence or absence of new DLs, on any teeth from the right second premolar to the
leJ second premolar in both arches, assessed using the pre-treatment and day of debond clinical pho-
tographic images. Minimum of 3 and maximum of 5 assessors
Secondary outcomes: judgements about the aesthetic appearance of new DLs, as well as the number
of first time bond failures (any bracket anterior to the first molars) during treatment, taken from clinical
records
Notes Funding source: Sheffield Hospitals Charitable Trust and GC Corporation donated a proportion of the
Fuji ORTHO™ LC bonding adhesive
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomisations using a computer generated random number sequence
stratified on the operator to ensure that each operator was allocated the same
number of participants in the 2 groups
Allocation concealment
(selection bias)
Low risk Sequentially numbered opaque envelopes at each centre
Blinding - Patients & Oper-
ators
Unclear risk Blinding of patients and operators not possible because of the nature of the 2
materials. Not sure if this would affect the outcome, because it is not certain
if or how participants or operators might change their behaviour as a result of
knowing they were in one group or the other. The impact of this is unclear
Blinding - Outcome asses-
sors




Low risk 4 participants dropped out as they moved away, but 9 were withdrawn from
2 centres because these centres failed to recruit a useful number of pa-
tients. 23 participants had missing final photographs and 1 had inadequate
photographs. Dropouts and withdrawals equally distributed between the
groups. The risk of bias was considered low as in the worse scenario (all those
dropouts and withdrawals who were bonded with composite had new DLs) the
risk ratio changed from 1.25 (95% CI 0.74 to 2.13) to 0.73 (95% CI 0.48 to 1.13)
and the conclusions (no difference in the incidence of new DLs) would be the
same
Free of selective reporting Low risk Relevant outcomes reported, including whether or not the DLs were consid-
ered unaesthetic and bond failures (not part of this review)
Free of other bias Low risk According to flow diagram all participants randomised received their allocated
intervention. No protocol deviations were reported. Complete-case analysis
undertaken presumably (but not reported) based on the assumption that data
for participants who withdrew or dropped out were missing at random (MAR),
which seems reasonable. Stratification by operator meant that participants
Benson 2019  (Continued)
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in 1 setting had an equal chance of being in either group. This should account
for confounders, such as difference in treatment materials and methods by dif-
ferent operators and environmental factors, such as level of fluoride in water




Methods Design: single centre, randomised controlled trial, assessing superiority with 3 parallel groups
Unit of randomisation: participant
Setting: 1 centre (Department of Stomatology, the Fourth People's Hospital of Shenzhen, Shenzhen
City, China)
Recruiting period: June 2007 to September 2009
Participants Inclusion criteria: from translation "with fixed orthodontic" - but need to check they were recruited and
allocated before the fixed was placed, although mean duration of experimental period would suggest
that this was the case
Exclusion criteria: from translation: "Participants with dental hard tissue well developed, without tetra-
cycline teeth or dental fluorosis, and without cavities or fillings on the buccal surface"
Mean age at baseline, years: mean age 14.3 years (range 12 to 17 years, no SD provided)
Number randomised: 75 (25 in each group)
Number evaluated: 75 (intention-to-treat)
Duration of treatment: Group A: mean 21.3 months, Group B: mean 22.7 months, Group C: mean 21.6
months (range 18 to 24 months; no SD was reported)
Interventions Group A (experimental group): fluor protector (Vivadent, Swiss) per 3 months by the dentist + Bass
method of toothbrushing
Group B (alternative intervention group): tooth mousse (GC, Japan) (complex of casein phosphopep-
tide amorphous calcium phosphate, CPP-ACP) per night by the participant's self + Bass method of
toothbrushing
Group C (placebo group): Bass method of toothbrushing
Outcomes Primary and secondary outcomes not explicitly stated and no justification of sample size therefore pri-
mary outcome cannot be inferred
Measured DLs using the Enamel Demineralization Index (EDI) devised by Mizrahi (1982) recorded using
photographs
Abstract states "After finishing the orthodontic treatment, photos were taken under the same condition
[sic], then the degree of enamels [sic] demineralization was examined." This suggests that photographs
were taken before and after treatment, but not clear if they were compared and only new DLs scores
Notes Funding source: abstract states "Supported by Research Fund of Bureau of Science and Technology of
Futian District Shenzhen City (Grant Number FTWS056)
No sample size calculation
Not reported whether participants used additional oral measures, such as toothpastes with or without
fluoride
A message, asking for additional information, sent to the first author contact details in the report (He
Wen-dan hewendan@yahoo.com.cn) on 8 August 2018, but was returned as undeliverable
Risk of bias
He 2010 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Translation: "In the order of treatment time, participants were divided ran-
domly into 3 groups." No details of method of randomisation, stratification
and how they achieved equal numbers in the 2 groups
Allocation concealment
(selection bias)
Unclear risk No details
Blinding - Patients & Oper-
ators
Unclear risk Participants received different preventative regimens, at different times,
therefore neither participants or operators could be masked. The impact of
this is unclear
Blinding - Outcome asses-
sors
Unclear risk Translation: "EDI was measured by our research member(s) who was/were
blind to the treatment." Not clear how many assessors were involved
Incomplete outcome data
addressed
Low risk No dropouts (quite unusual over the more than 2-year period of the study)
Free of selective reporting Unclear risk The definition of incidence is unclear (difference between start and finish -
new DLs or just at the finish?). Also report "the incidence of teeth's enamel cal-
cification [sic]" and do not state how they took into account the clustering of
teeth within the mouth
Free of other bias Unclear risk Not reported how many operators were involved in the study or whether par-





Methods Design: single centre, randomised controlled trial, assessing superiority with 2 parallel groups
Unit of randomisation: participant, no reported stratification
Setting: 1 centre, Orthodontic Department Hospital of Stomatology, Wuham University, China
Recruiting period: July 2007 to December 2010
Participants Inclusion criteria: 10 and 20 years old, satisfactory general health, requiring fixed orthodontic treat-
ment for at least 6 months
Exclusion criteria: periodontal probing depth greater than 3 mm; history of long-term use of antibiotics;
active caries; enamel hypoplasia, dental fluorosis, or tetracycline-stained teeth
Mean age at baseline, years: 13.5 SD 2.2 years (range not reported)
Number randomised: 100 (50 experimental foam, 50 control foam)
Number evaluated: 95 (48 experimental foam, 47 control foam)
Duration of treatment: 18 months (SD 3.2, range 10.6 to 32 months)
Interventions Comparison: 12,300 ppm F acidulated phosphate fluoride (APF) foam (Dentology, Suntech Medical Ap-
pliances Co, Ltd, Beijing, China) versus fluoride-free (0 ppm F) foam prepared by the same company.
Professionally applied in trays for 4 minutes every 2 months
Jiang 2013 
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Outcomes Primary outcomes: 2 reported - incidence of 'WSLs' (per cent) and the increment of 'WSLs' scores dur-
ing orthodontic treatment; however sample size calculation based on detecting a mean difference of
2.0 'WSL' increments (Gorelick index)
Secondary outcome: distribution of 'WSLs' score (per cent) in both the 1.23 per cent APF foam and
placebo groups after debonding
Assessed by 1 calibrated and masked examiner before and on day of debond
Notes Funding source: National Key Technologies R&D Program of the Eleventh-five Year Plan, the Ministry of
Science and Technology of China, Beijing (no 2007BAI18B01)
Data presented for teeth not for participants on report but clarification obtained from study authors
Corresponding authors (Baojun Tai - taibaojin@126.com, Minquan Du - minquandu@163.com) contact-
ed 8 August 2018 for data on participant with new DLs and to clarify aspects of methodology, including
method of randomisation and allocation concealment. No response so follow-up e-mail on 22 January
2019 and response eventually received 5 September 2019
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The report states that random sequence was generated using a "table of ran-
dom numbers", but it was not clear how they achieved equal numbers in




Unclear risk The reports states that the "subjects, clinicians, and examiners were blind to
group allocations" however the exact method of allocation concealment was
unclear. The authors were contacted and replied that "No particular methods
were used to conceal the random sequence", so this is still unclear
Blinding - Patients & Oper-
ators
Low risk Both foams had the same consistency, appearance and odour stored in same
bottles labelled A or B
Blinding - Outcome asses-
sors
Unclear risk Examiner blind to group allocation. Only 1 assessor undertook clinical assess-
ments. Report does describe that the examiner was involved in an "initial cal-
ibration", but not clear if this was maintained for the full length of the trial. In-
traexaminer agreement assessed on 10 patients (kappa 0.75), but better to
have multiple assessors to reach a consensus
Incomplete outcome data
addressed
Low risk Low number of reported dropouts and withdrawals (5 out of 100 participants
randomised, 5%)
Free of selective reporting Low risk Unclear if Table 2 refers to proportion of participants affected or proportions
of teeth affected. The authors were contacted and have supplied the data for
the numbers of participants with at least 1 new DL
Free of other bias Unclear risk According to flow diagram (Figure 1) 10 participants were excluded between
'enrolment' and randomisation, but it is not clear why. No protocol deviations
reported. Complete-case analysis undertaken presumably (but not reported)
based on the assumption that data for participants who withdrew or dropped
out were missing at random (MAR), which seems reasonable. Unclear how
many operators were involved
Participants were "instructed to brush their teeth twice daily with the tooth-
brushes (V type) provided" and "forbidden from using any other oral hy-
giene measures or using fluoride in addition to fluoride toothpaste." Suggests
they were allowed to use fluoride toothpaste (1450 ppm?), but no other
mouthrinse. Not clear if GDP provided topical fluoride. Fluoride concentration
Jiang 2013  (Continued)
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in the drinking water was low (0.1 to 0.3 ppm), but participants were all from





Methods Design: randomised, placebo-controlled, parallel-group trial
Unit of randomisation: participant
Setting: 2 centres (Berlin, Germany and Jerusalem, Israel)
Recruiting period: not stated
Participants Inclusion criteria: healthy; aged 10 years or older; 10 teeth or more to be bonded with fixed orthodontic
appliances labially; highly effective birth control for girls and women of child-bearing age. The reason
for the latter inclusion criteria is unclear
Exclusion criteria: known allergy to one of the components of the test products; disabled and unable to
brush their own teeth; pathological desquamation changes; known pregnancy; breastfeeding; eating
disorders; enamel or dentine disorder; participation in another clinical trial within 30 days
Screened: 321; randomised: 320 (additional report states 321 – checking with study authors); ITT analy-
sis n = 312
Mean age at baseline: 16 years (SD 7) intervention group; 16 years (SD 6) placebo control
Slightly higher proportion of males in intervention group (50.6% versus 42.9%) and most were of Cau-
casian origin (88.5% versus 91.7%)
Mean treatment duration: 16.6 months (SD 7.3; range 1.3 to 32.5 months)
Interventions Comparison: amine fluoride-containing gel (Elmex® gel) (1.25% fluoride, including 1% fluoride from
NaF and 0.25% fluoride from olaflur/dectaflur, approximately 12,500 ppm; 10% solution pH 4.3-5.3) ver-
sus placebo gel (comparator product formulation number 447/2221; 10% solution pH 6.5-7.5)
pHs were different, but presume the 2 gels were identical in taste, colour; consistency and packing
Home gel brushing, once per week, approximately 0.5 g gel
Tray application 4 times per year, approximately 8 g gel
Study products manufactured by Colgate were delivered to the study site by GABA GmbH Lörrach (Ger-
many) or TEVA Pharmaceuticals, Netanya (Israel)
Participants were reminded by SMS or e-mail once a week, to brush their teeth with their gel and to
bring along their study products to each visit (normally every 6 weeks) for weighing
Outcomes Primary outcome: time and frequency of visually detected DLs according to modified DMFS (D1 'white
spot' < 2 mm; D2 'white spot' > 2 mm; D3 cavitation; D4 cavitation deep into dentine; M missing due to
caries; F filled) and bitewing radiographs. Occurrence of a DL was defined as: cavitation; any DL exceed-
ing 2 mm in any direction; new or progressing approximal lesion detectable by bitewing radiographs;
more than 4 teeth affected with DLs of any size
Secondary outcomes: frequency of DL (endpoints, based on patients and teeth); time of occurrence of
DL (endpoints); mineral loss according to QLF findings; changes in the caries index according to modi-
fied DMFS; radiographic findings on bitewings during the study; approximal plaque index (API)
Jost-Brinkman 2017 
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At baseline (before orthodontic bonding), each participant underwent examination - visual, radi-
ographic bitewings, QLF measurements. The final visit took place at the end of the 30-month study or
after debonding
Notes Funding: Colgate-Palmolive Europe Sàrl, (Colgate)
Sample size calculation based on a time-to-event analysis for the occurrence of new DLs, testing the
following hypothesis with a log-rank test: DLs occur earlier in patients using the placebo gel (without
fluoride) than in patients using the fluoride gel (Elmex® gel)
Paul-Georg Jost-Brinkmann (Paul-G.Jost-Brinkmann@charite.de) contacted 19 December 2018 to clari-
fy some issues (Were the assessments carried out on the day of debond? If not how long after? Who car-
ried out these assessments? Were they calibrated? Any reproducibility assessments undertaken?). No
reply so follow-up e-mail sent 22 January 2019
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "The study participants were randomly allocated to one of the two
study groups"
Comment: no details of method of random sequence generation or if a block
design or stratification was used
Allocation concealment
(selection bias)
Low risk Investigator "received a sealed random-code envelope for each individual sub-
ject number." The sealed envelopes were to be opened only in case of emer-
gency when knowledge of the actual treatment was medically necessary
Blinding - Patients & Oper-
ators
Low risk Quote: "Patients, investigators, study monitors, study coordinators, and data
managers were unaware of the study product being administered"
Blinding - Outcome asses-
sors
Unclear risk Quote: "Patients, investigators, study monitors, study coordinators, and data
managers were unaware of the study product being administered"
Comment: unclear who and how many undertook the clinical assessments,




Unclear risk Screened: 321; randomised: 320 (additional report states 321 – checking with
study author); eligible for the safety analysis: 318
ITT analysis (all randomised patients who received at least 1 dose of the study
product and had at least 1 assessment of efficacy: n = 312 (Elmex® gel: n =
156, placebo gel: n = 156) - not clear why 8 or 9 were excluded from those ran-
domised (no flow diagram); per-protocol analysis (all randomised patients
who satisfied the following criteria: no missing data for the primary efficacy
variable; no major protocol violations) n = 265 (Elmex® gel: n = 135, placebo: n
= 130)
Authors state that "In 15 patients in the Elmex® gel group and 15 patients in
the placebo group, non-compliance with the study requirements led to the
premature discontinuation of the study (ITT set)", but only 8 were excluded
according to the above figures (checking with study authors). They go on to
state that "only a small number of patients (n = 5; Elmex®: n = 1; placebo: n =
4) were excluded from the PP analysis because of non-compliance" and "The
main reason for excluding patients from the PP analysis set was the use of dis-
allowed concomitant medications, both in the Elmex® gel and placebo gel
groups"
Jost-Brinkman 2017  (Continued)
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The Statistical Summary Tables ITT documentation (Appendix 12.5 - request-
ed) provides the complete listing of individual reasons for exclusion from the
per-protocol analysis
Free of selective reporting Low risk Thorough report into complete list of adverse events occurring to participants
during the study. Most were nothing to do with taking part in the trial
Free of other bias Unclear risk Protocol deviation reported for the analysis, as they examined data for num-
ber of teeth rather than number of participants. Unclear how many opera-
tors were involved in each centre, but unlikely to be a significant risk of bias.
If they had stratified the randomisation by setting this would have meant that
participants in 1 setting had an equal chance of being in either group. This
would have accounted for confounders, such as difference in treatment mate-
rials, methods by different operators and other sources of fluoride from diet
or water. Participants could use their own toothpaste, but not clear if GDP was




Methods Trial design: single centre, randomised controlled trial, assessing superiority with 2 parallel groups
Unit of randomisation: participant, no stratification reported
Setting: 1 centre, teaching hospital, Leeds UK
Recruitment period: December 1998 to December 1999
Participants Inclusion criteria: participants with upper incisors and canines developing and at least 3 upper perma-
nent incisors and 1 upper permanent canine erupted, prior to commencement of orthodontic treat-
ment with fixed upper appliances
40 female/28 male (numbers incorrect as 70 were randomised)
Exclusion criteria: participants with grossly damaged, restored or defective upper permanent canines
or incisors, participants living in areas with fluoridated water supply, physically or mentally handi-
capped individuals, those with comorbidities or requiring antibiotic cover and pregnant or nursing fe-
males
Mean age at baseline, years: 15.7 years (range 11 to 45)
Number randomised: 70 (34 fluoride-releasing glass bead and 36 fluoride rinse)
Number evaluated: 37 (18 fluoride-releasing glass bead and 19 fluoride rinse)
Duration of treatment: approximately 19 months (recruitment ended December 1999; final data collec-
tion September 2002)
Interventions Comparison: fluoride-releasing glass beads versus fluoride mouthrinse
Group A (n = 18): fluoride-releasing glass bead (containing 13.3% F) attached to appliance 
Group B (n = 19): fluoride rinse (Endekay 0.05% NaF). Participants instructed to use 5 drops in 10 ml of
water and to rinse once daily
Outcomes Primary outcome: not explicit, but did assess presence or absence of new DLs assessed from before
and after cross-polarised images of 6 upper anterior teeth. 1 masked assessor using image analysis
Secondary outcomes: not explicit, but measured salivary fluoride levels
Luther 2005 
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Notes Funding source: BDA Research Foundation Shirley Glasstone Hughes Memorial Prize Fund and the Lis-
terine Preventive Care Award
Background exposure to fluoride not reported: unclear whether participants used fluoride toothpaste
Power calculation reported that 28 participants/group would be needed to show the expected 75% dif-
ference (high); it was planned to recruit 35 per group to allow for dropouts
Large numbers of participants both withdrawing or dropping out (total 14: 6 control, 8 experimental),
as well as insufficient data for analysis (total 19: 11 control, 8 experimental). Null findings should be in-
terpreted with caution, as investigators lost so many in their sample, which means that it is likely that
this study lacks statistical power, hence no conclusion overall can be made about this intervention
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Quote: "Each time a patient agreed to take part in the study, a dental nurse
who was not involved in the running of the study accessed the concealed table
and crossed oG the next number, informing the operator of the treatment to
be used i.e. whether the patient had been allocated to the fluoride rinse or FGB
group"
Blinding - Patients & Oper-
ators
Unclear risk Not possible to blind participants or operators to allocated intervention. The
impact of this is unclear
Blinding - Outcome asses-
sors
Low risk Quote: "Analysis was undertaken blind by one operator, who was unaware of
which group the teeth being analysed came from"
Incomplete outcome data
addressed
High risk 14 participants (8 fluoride-releasing glass bead and 6 mouthrinse) dropped
out - reasons not given. Further 19 (8 fluoride-releasing glass bead and 11
mouthrinse) excluded from analysis because of insufficient data, and reasons
not explained. 47% of randomised participants not included in the analysis.
High rate of breakage of fluoride-releasing glass beads. Substantial risk of at-
trition bias due to dropouts and withdrawals (33 out of 70 randomised; 47%)
Free of selective reporting Unclear risk Numbers of participants and teeth with DLs reported at the beginning and at
the end of the trial, but denominators were unclear. No indication of mean size
of lesions in each group. Salivary fluoride levels not reported
Free of other bias Unclear risk Number of breakages of fluoride-releasing glass beads reported, but no indica-
tion of level of compliance in fluoride rinse group. No information on duration




Methods Trial design: 2-centre, parallel-group randomised controlled trial
Unit of randomisation: participant, no stratification
Setting: 2 orthodontic clinics of Falköping and Lidköping in Sweden
Recruitment period: starting orthodontic treatment in 1999, last patient debonded November 2003
Ogaard 2006 
Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment (Review)









Cochrane Database of Systematic Reviews
Participants Inclusion criteria: participants were those starting orthodontic treatment in 1999 with fixed appliances
in both arches
Exclusion criteria: none stated
Age at baseline: mean 14.5 years
Number randomised: 115
Number evaluated: 97 (numbers per group not stated)
Duration of treatment: "average approximately 1.5 years"
Interventions Comparison: 2 different fluoride toothpastes and mouthrinses
Group A (n = 50): participants were instructed to brush twice daily with toothpaste containing amine
fluoride and stannous fluoride combination (AmF/SnF2 140 ppm, pH 4.5) and to rinse every evening af-
ter toothbrushing with a solution containing amine fluoride and stannous fluoride
Group B (n = 47): participants were instructed to brush twice daily with toothpaste containing neutral
sodium fluoride (NaF 1400 ppm, pH 6.7) and to rinse every evening after toothbrushing with a solution
containing NaF (250 ppm, pH 6.3)
Fluoride treatments were continued for the whole duration of orthodontic treatment with fixed appli-
ances
Outcomes 'White spot lesion' index, visible plaque index, gingival bleeding index, measured at baseline and at
debonding
Notes Funding source: the study was supported by GABA International, Basel, Switzerland
Background exposure to fluoride: not reported
Power calculation: not reported
Corresponding author contacted (Bjørn Øgaard - bogaard@odont.uio.no) contacted by e-mail (14 Au-
gust 2018) for clarification about a number of issues. Replied 24 September 2018 "Thank you for your
interest in the cited study about white spot lesion development in orthodontic patients. I am sorry
for the late response, but I have almost retired. The study was carried out in Sweden for more than 15
years ago. The investigator in charge died two years ago, and the statistician has retired many years
ago. However, I will try to answer your questions below." Follow-up message on 22 January 2019
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "allocated to two groups at bonding according to a randomized table"
Comment: assumed this refers to random number table, but it is not clear how
they achieved equal numbers in each group
Allocation concealment
(selection bias)
Unclear risk Not described
Comment: assumed not done
Blinding - Patients & Oper-
ators
Unclear risk Quote: "The toothpaste tubes/bottles were similar and coded either A or B.
The colour and taste of the toothpastes and the rinsing solutions were as close
to identical as possible"
Comment: the above suggests they were not identical and operator and/or
participant might be able to guess which group they were allocated to
Ogaard 2006  (Continued)
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Blinding - Outcome asses-
sors
Unclear risk Quote: "Neither the subjects nor the research team were informed about
which group each participant belonged to"
Comment: the report indicates that clinical assessments and colour pho-
tographs were obtained prior to bonding and at debond, but does not state
that the photographs were used in the assessment. No details about who car-




Unclear risk No flow diagram. Report that of the 115 patients "initially invited to partici-
pate" 18 "did not complete treatment according to the requirements in the
protocol in 2003." Not stated which groups they were from or reasons for with-
drawal or dropout apart from "mainly due to moving." Moderate risk of attri-
tion bias for demineralisation assessments due to dropouts and withdrawals
(16%). Unable to calculate the risk ratios because of the type of data present-
ed, therefore the impact of the withdrawals and dropouts is unclear
Free of selective reporting Unclear risk Only data on mean changes in 'white spot index' before and after reported. No
data on number of participants with new DLs in each group
Free of other bias Low risk Presumably the orthodontic clinics were public facilities and not private prac-
tices. Unclear how many operators were involved in each centre. If they had
stratified the randomisation by setting or operator this would have meant that
participants in 1 setting had an equal chance of being in either group. This
would have accounted for confounders, such as difference in treatment mate-
rials and methods by different operators. Both groups were supplied with the
same type of toothbrush (GABA). Not clear if participants were encouraged to
use any other fluoridated products or GDP informed about not applying flu-
oride. Environmental factors, such as level of fluoride in water supply should
not be a factor as Sweden has a low level of public water fluoridation, which




Methods Trial design: multicentre, randomised controlled trial, assessing superiority with 2 parallel groups
Unit of randomisation: participants, no stratification reported
Setting: 5 centres, 4 public specialist clinics and 1 university teaching hospital in southern Sweden
Recruitment period: started "2008" and "trial was completed in May 2012." Unclear what the recruit-
ment period was
Participants Inclusion criteria: aged 11 to 16 years, 2-arch pre-adjusted edgewise fixed appliances, treatment dura-
tion at least 1 year
Exclusion criteria: participants with special needs, such as chronic diseases and/or disabilities
Mean age at baseline, years: test group (high fluoride (HF)) 14.8, SD 1.7 years; control (conventional
adult fluoride (CF)) 14.6, SD 1.7 years
Number randomised: 424 (211 HF; 213 CF)
Number evaluated: 380 (188 HF; 192 CF)
Duration of treatment: 1.8 years (SD 0.53)
Sonesson 2014 
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Interventions Comparison: high fluoride toothpaste (5000 ppm) versus conventional adult fluoride toothpaste (1450
ppm) used at home by participants
Outcomes Quote: "Primary and secondary outcomes were the prevalence and incidence of WSL at time of
debonding"
Sample size based on difference in proportion of participants with new DLs at debonding, so this is pri-
mary outcome and therefore measuring incidence
Secondary outcome: severity according to Gorelick Index
Assessed from projected pre and post-treatment digital photographic images, by 2 masked "experi-
enced and calibrated orthodontists." Disagreements resolved by re-examination of photographs and
discussion. Agreement assessed using 50 participants images after 1 month (interexaminer kappa sta-
tistic 0.70, intraexaminer kappa 0.80)
Notes Funding source: the Swedish Patent Revenue Fund 2007; toothpaste and toothbrushes donated by Col-
gate-Palmolive
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Computer generating"
Comment: no stratification or block allocation mentioned
Allocation concealment
(selection bias)
Low risk Sequentially numbered opaque envelopes supplied by "an independent per-
son, not involved in the treatments or data analyses"
Blinding - Patients & Oper-
ators
Unclear risk Toothpaste supplied by Colgate-Palmolive and described as same flavour and
consistency; however the study was not truly triple-blind. Quote (Discussion
page 681): "...we were unable to secure a true double-blind performance of
the study because it was not possible for the manufacturer to produce identi-
cal packing of the two different toothpastes. Even if the participating subjects
were not informed on the different toothpaste characteristics, it was not un-
likely that they became aware of their assignment during the study period, es-
pecially since the diameter of the tube openings differed"
Blinding - Outcome asses-
sors




Unclear risk 44 out of 424 (10%) randomised were dropouts or withdrawals and reasons
were included in flow diagram. However, the authors report that 18 partici-
pants (HF 10; CF 8) "did not comply with the study protocol" and were exclud-
ed from the analysis, but the definition of non-compliance is unclear. Conse-
quently a per-protocol rather than an intention-to-treat analysis was under-
taken. In the worse scenario (all participants in the experimental group who
dropped out or withdrew had new DLs) the risk ratio changes from 0.68 (95%
CI 0.46 to 1.00) to 1.02 (95% CI 0.74 to 1.41)
Free of selective reporting Low risk Relevant outcomes reported. Measure of severity was Gorelick Index, which
is relatively crude. The "vast majority" of new lesions (98.8% HF; 97.7% CF) as
"slight white spot formation (thin rim)" and therefore probably not an aesthet-
ic problem.
Free of other bias Low risk Unclear how many operators were involved in each centre, but multiple opera-
tors makes this a 'real world' study. It might have been better to have stratified
the randomisation by setting or operator, which would have meant that par-
ticipants in 1 setting had an equal chance of being in either group. This would
Sonesson 2014  (Continued)
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have accounted for confounders, such as difference in treatment materials
and methods by different operators. Not clear if participants were encouraged
to use any other fluoridated products. Environmental factors, such as level of
fluoride in water supply should not be factor as Sweden has a low level of pub-




Methods Trial design: 3-centre, randomised controlled trial, assessing superiority with 2 parallel groups
Unit of randomisation: participants, stratified on centre
Setting: 3 orthodontic specialist clinics (1 university, 2 private) in Scania region, Sweden
Recruitment period: January 2015 to November 2017
Participants Inclusion criteria: scheduled treatment with direct bonded fixed maxillary pre-adjusted edgewise appli-
ances during a period of at least 12 months
Exclusion criteria: severe chronic conditions such as asthma and allergy, neuropsychiatric disorders
and regular use of oral antiseptics and previous fixed orthodontic appliance treatment
Mean age at baseline, years: test group (high fluoride (HF)) 14.1 years, SD 1.7, range 11.3 to 18.7 years;
control (conventional adult fluoride (CF)) 13.8 years, SD 1.8, range 10.1 to 18.0 years
Number randomised: 166 (85 HF; 81 CF)
Number evaluated: 148 (75 HF; 73 CF)
Duration of treatment: 1.7 years (SD 0.5)
Interventions Comparison: high fluoride varnish (7700 ppm ammonium fluoride dissolved in ethanol, water and acry-
late polymer - Fluor Protector S, Ivoclar Vivadent, Liechtenstein) versus no fluoride varnish
All patients seen every 6th week for wire adjustment. Test or control varnish applied by clinical staG at
the end of each visit with a small brush around the base of the brackets in the upper arch. This was leJ
to dry for 1 minute and participants instructed not to eat or drink within 60 minutes. Participants were
encouraged to brush twice a day with a 1450 ppm fluoride toothpaste. No additional fluoride recom-
mended
Outcomes Primary outcome: "prevalence and severity" of DLs, but sample size based on detecting a 15% differ-
ence between the 2 groups (which difference not specifically stated, but presumably number of DLs).
Pre and post-treatment photos projected on a screen and scored by 2 "experienced and calibrated spe-
cialists" using Gorelick Index (reported data for before and after so incidence or new DLs assessed).
When in doubt lower score give, disagreements resolved through consensus (presumably between 2
assessors)
Secondary outcomes: severity of DLs
Notes Funding from "author's institutions and partly supported by Ivocalr Vivadent AG" who provided the
varnishes
Water is not fluoridated in Sweden
Risk of bias
Bias Authors' judgement Support for judgement
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Random sequence genera-
tion (selection bias)
Low risk Computer generated random sequence, blocks of 15, but on further enquiry
author replied that the centres recruited in blocks of 30 (1 centre 90, 1 centre
60, 1 centre 30 - 15 test and 15 controls)
Allocation concealment
(selection bias)
Low risk Not in the report, but authors replied "consecutive numbers" and the "list was
secured by .....a person not involved in the clinical part of the trial"
Blinding - Patients & Oper-
ators
Low risk Taste, colour, handling and packing the same for both varnishes therefore nei-
ther participant or clinician were aware of group allocation
Blinding - Outcome asses-
sors
Low risk Scoring done on photographs and the lead study author confirmed that the




Low risk All accounted for
Free of selective reporting Low risk Flow diagram provided and accounts for withdrawals and dropouts reported
(10/85 or 12% experimental; 8/81 or 10% controls). Reasons given and similar
in each group. Assuming the worse scenario (all participants in experimental
group who dropped out or withdrew had new DLs) this would change the risk
ratio from 0.96 (95% CI 0.65 to 1.41) to 1.34 (95% CI 0.97 to 1.86) and would not
change the interpretation of the findings
Free of other bias Low risk According to the flow diagram all participants randomised received their allo-
cated intervention. No protocol deviations reported
Complete-case analysis undertaken presumably (but not reported) based on
the assumption that data for participants who withdrew or dropped out were
missing at random (MAR), which seems reasonable. Unclear how many op-
erators were involved in each site, but multiple operators makes this a 're-
al-world' study. Randomisation stratified by site means that participants in 1




Methods Trial design: 2-centre, randomised controlled trial, assessing superiority with 2 parallel groups
Unit of randomisation: participants, no stratification reported
Setting: 2 public orthodontic clinics at Skelleftea and Lycksele, northern Sweden
Recruitment period: not stated
Participants Inclusion criteria: children 12 to 15 years of age scheduled for maxillary treatment with fixed orthodon-
tic appliances for an expected duration of at least 6 months
Exclusion criteria: none stated
Mean age at baseline, years: 14.3 SD 1.6 years
Number randomised: 273 (137 fluoride varnish; 136 placebo varnish)
Number evaluated: 257 (132 fluoride varnish; 125 placebo varnish)
Duration of treatment: not given, but mean number of applications of varnish was 10, and assuming
they were seen every 6 weeks, the mean duration was 60 weeks or just over 1 year (which is quite short)
Interventions Comparison: fluoride varnish (Fluor Protector) versus placebo varnish
Stecksén-Blicks 2007 
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Group A (n = 137): Fluor Protector varnish (0.1% F difluorosilane in polyurethane base, which is 1000
ppm fluoride in a homogeneous solution; however, according to the manufacturer's literature, after
the varnish has dried, the concentration is approximately 10 times higher) applied after bonding and at
each check-up (approximately every 6 weeks) until debonding
Group B (n = 136): placebo varnish, identical in appearance to active, applied after bonding and at the
end of each check-up (every 6 weeks) until debonding
In both groups, after removal of visible plaque with an explorer, 0.2 to 0.3 ml varnish was applied
around the bracket bases in a thin layer with a minibrush and was allowed to dry for 2 minutes. Partic-
ipants were instructed to avoid all eating and drinking for 2 hours and to not brush teeth until the fol-
lowing day
All children strongly advised to brush teeth with 1000 to 1500 ppm fluoride toothpaste at least twice
daily
Fluoride in piped drinking water in these communities was < 0.2 ppm
Outcomes Primary outcome: reported as "incidence or progression" or DLs. Sample size based on a 20% reduc-
tion in the incidence therefore this is the presumably the primary outcome and severity (as judged by
Gorelick Index) is a secondary outcome. Before and after clinical photographs assessed for presence
and severity of DLs by 2 "experienced and calibrated judges." Disagreements resolved and consensus
achieved through discussion. Interexaminer agreement (kappa statistic 0.69) and intraexaminer agree-
ment (kappa 0.77) determined by repeat assessments on random 50 participant records after 1 month
Notes Funding source: grants from the County Council of Vasterbotten and Swedish Dental Society, with var-
nishes supplied by Ivoclar Vivadent and brackets by 3M Unitek
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote (author): "The patients were assigned to one of the two groups on the
basis of odd and even numbers from a dice"
Comment: the corresponding author was asked how investigators obtained
equal numbers in all groups but does not seem to have answered this
Allocation concealment
(selection bias)
Low risk Quote (author): "The study was coordinated from the Department of Paedi-
atric Dentistry and the randomization was performed there by an independent
technician not involved in the clinical work and collection of data"
Comment: presumably remote allocation through telephone, but author has
not confirmed
Blinding - Patients & Oper-
ators
Low risk Quote (author): "The placebo varnish applied had an identical composition
but without fluoride. Both varnishes were uncoloured and obtained from the
producer in identical bottles coded by colour. Neither clinicians nor patients
knew whether they were treated with fluoride or placebo varnish"
Comment: the study was double-blind
Blinding - Outcome asses-
sors
Low risk The two "experienced and calibrated" judges who scored the photographs for
presence/absence and severity of DLs "were not involved in the treatment of
the patients and blinded for group assignment"
Incomplete outcome data
addressed
Low risk Flow diagram provided and withdrawals and dropouts reported (5/137 or 4%
experimental; 11/136 or 8% control). Reasons given and similar in each group.
Assuming the worse scenario (all participants in experimental group who
dropped out or withdrew had new DLs) this would change the risk ratio from
Stecksén-Blicks 2007  (Continued)
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0.27 (95% CI 0.13 to 0.54) to 0.39 (95% CI 0.22 to 0.71) and would not change
the interpretation of the findings
Free of selective reporting Low risk Planned outcome was 'white spot lesions' at debonding in each group. Report-
ed as percentage of prevalence with P value for difference between groups.
According to Figure 2 there were a very low proportion (< 3%) of Gorelick In-
dex scores of 3 ('Excessive white spot formation (thicker bands)'). The majority
were scored 2 ('Slight white spot formation (thin rim)'), so the aesthetic impact
is unclear
Free of other bias Low risk According to the flow diagram all participants randomised received their allo-
cated intervention. No protocol deviations reported
Complete-case analysis undertaken presumably (but not reported) based on
the assumption that data for participants who withdrew or dropped out were
missing at random (MAR), which seems reasonable. Unclear how many oper-
ators were involved in each centre, but multiple operators makes this a 're-
al-world' study. If they had stratified the randomisation by setting or operator
this would have meant that participants in 1 setting had an equal chance of
being in either group. This would have accounted for confounders, such as dif-
ference in treatment materials and methods by different operators. Not clear if
participants were encouraged to use any other fluoridated products. Environ-
mental factors, such as level of fluoride in water supply should not be factor as





Methods Design: single centre, randomised controlled trial, assessing superiority with 2 parallel groups
Setting: 1 teaching hospital orthodontic department, Amsterdam, the Netherlands
Recruitment period: April 2009 to January 2011
Participants Inclusion criteria: aged 10 to 18 years, good general health, no medications, "no demineralizations
in need of restorations present at a buccal surface." Go on to state that all "received fixed appliances
(Roth Ovation) in both jaws"
Exclusion criteria: none stated
Mean age at baseline, years: 13.3 years (range 10.0 to 16.6): fluoride 13.1 years (range 10.0 to 16.6),
placebo 13.6 years (range 11.7 to 16.5)
Number randomised: 120 (61 fluoride; 59 placebo)
Number analysed: 81 (36 fluoride; 45 placebo)
Duration of treatment: 24.5 months (SD 5.5)
Interventions Comparison: 250 ppm fluoride mouthrinse (100 ppm amine F; 150 ppm NaF) versus placebo
mouthrinse (0 ppm F) used at home by participants
Outcomes Primary outcome: number of DLs, determined by QLF as measured by a single trained and calibrated
examiner. Figure 1 seems to indicate that QLF images were collected on day of debond, but Table 2 in-
dicates that the data collected at a mean of 6 weeks (range 0 to 156 days) were used in the analysis
Pre-treatment images were subtracted from post-treatment images, so did measure incidence
Secondary outcomes: severity of DLs (fluorescence loss and lesion depth from QLF), ICDAS, DMFS,
bleeding indices. Authors state that number of lesions per participant was calculated and, for every
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participant having at least 1 lesion, mean fluorescence loss and area were calculated, so this took into
account clustering of teeth within the mouth
Notes Funding source: authors declare that study was "supported by Elmex research/Colgate-Palmolive Eu-
rope"
Corresponding author (Nicoline van der Kaaij - n.vd.kaaij@acta.nl) contacted 21 August 2018 for clarifi-
cation of some issues. No reply, follow-up message sent 22 January 2019 to which a reply was received
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Report not clear. Author response (24 January 2019): "In Excel, a list with 120
unique random numbers was created and then fixed by an independent re-
searcher. These were alternatingly allotted group A or B (60 in each group, sec-
ond column). Then the list was ordered from small to large numbers, giving a
random order of group assignment"
Allocation concealment
(selection bias)
Low risk Report not clear. Author response (24 January 2019): "The list with group as-
signments was controlled by the administration desk, were [sic] patients
schedule their appointments. Patients were assigned in the order of their last
appointment prior to bracket placement"
Blinding - Patients & Oper-
ators
Low risk Participants were provided with solution A or B. The bottles containing the
rinse were "tested and regulated by Colgate-Palmolive Europe" (presumably
prepared as well) and were identical in appearance, consistency, taste and
smell. Author response (24 January 2019): "Products were contained in identi-
cal flasks labeled: product for study use group A or B"
Blinding - Outcome asses-
sors
Low risk Quote: "after analysing all data obtained, the code regarding the rinse was
broken" so truly triple-blind
Incomplete outcome data
addressed
High risk Comprehensive flowchart provided with reasons for withdrawals and
dropouts. Substantial risk of attrition bias for demineralisation assessments
due to dropouts and withdrawals (39 out of 120; 33%). Even higher dropout
for secondary outcomes, particularly bleeding. A larger number "decided not
to participant any further" in the fluoride rinse group (10) compared with the
placebo rinse group (1). 17 participants were still in treatment when the study
was stopped, as "a result of unforeseen treatment complication or non-com-
pliance." A shame they were not followed to the end of treatment
Free of selective reporting Low risk Differences in the mean fluorescence loss and lesion difference between the 2
groups was small and not clear if the lesions were of aesthetic impact
Free of other bias Unclear risk According to flow diagram all participants randomised received their allocat-
ed intervention. No protocol deviations reported. Complete-case analysis un-
dertaken presumably based on the assumption that data for participants who
withdrew or dropped out were missing at random (MAR), however substan-
tial attrition of participants, partly because they decided to stop the trial be-
fore all participants had completed their orthodontic treatment (see Incom-
plete outcome data addressed box above).Treatment delivered by orthodontic
postgraduates, not clear how many and what level of experience. Participants
dentist "informed about study and instructed not to apply extra fluoride." Al-
so "Participants instructed not to use any fluoride-containing products other
than fluoride toothpaste", but this was not standardised. QLF images captured
by 1 trained and calibrated examiner. Not entirely clear if all the images were
collected and analysed from the day of debond, as they state "The WSL assess-
ments were made at an average of 52 days after debonding (with a range of 0
van der Kaaij 2015  (Continued)
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to 156 days)." Those undertaken at 5 months following debond might have un-
dergone quite extensive remineralisation unrelated to mouthrinse use
Author response (24 January 2019): "We did use the pictures of TD1 for
the WSL analyses (as is mentioned in the legend of figure 1 and in table
2). We choose this date since it is known that gingival swelling at time of
debonding can obscure a part of the lesion (Boersma et al, Caries Research
2005;39(1):41-7). The range was 0-156 days, with a mean of 52 and the me-
dian being 45 days. Indeed it is possible that remineralisation will happen
after debonding, in the study of M Beerens (European Journal of Orthodon-
tics 2018;40(5):457-64) it can be seen that only after 12 months there was a
significant difference in fluorescence loss, caused by remineralisation. At 6
weeks, 3 and 6 months after debonding no significant difference was seen in
that study. Also the study of T Matthousch (European Journal of Orthodontics
2007;29(3):294-8) showed no improvement at 6 weeks, and only at 6 months
an improvement in fluorescence loss. The range is because we did the re-
search in normal practice settings, thus patients cancelling there [sic] appoint-
ments or coming at not scheduled time points happened"
van der Kaaij 2015  (Continued)
CI = confidence interval; DLs = demineralised lesions; DMFS = decayed, missing and filled surface; F = fluoride; GDP = general dental prac-
titioner; ICDAS = International Caries Detection and Assessment System; ITT = intention-to-treat; LCC = light-cured composite resin; NaF =
sodium fluoride; ppm = parts per million; QLF = quantitative light-induced fluorescence; RM-GIC = resin-modified glass ionomer cement;
SD = standard deviation; WSLs = white spot lesions.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Al Mulla 2010 Compared modified fluoride toothpaste technique to normal toothbrushing rather than 2 fluoride
products
Alexander 2000 Clinical assessment carried out 1 month after debonding not immediately after
Alwi 1994 Abstract only. Insufficient information to include in review. Contacted author. Unable to provide
sufficient data for analysis. No subsequent publication identified
Banks 1997 Split-mouth study
Banks 2000 CCT with alternate allocation to fluoride or non-fluoride elastomeric ligatures
Blanco 1988 "Patients chosen at random" and divided into 2 groups. Report is unclear about the details of allo-
cation to each group, groups are unequal in size, no baseline characteristics, and no outcome da-
ta presented per participant. Unable to contact authors and unable to include this study based on
available information
Boyd 1992 Demineralisation assessed 3 months after debonding rather than immediately
Boyd 1993 Demineralisation assessed 3 months after debonding rather than immediately
Boyles 2007 Not RCT
Buyukyilmaz 1994 Split-mouth study
Chung 1998 Split-mouth study
Czochrowska 1998 Split-mouth study
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Study Reason for exclusion
D'Agostino 1988 Outcomes were DMFT and DMFS not demineralised white lesions
Demito 2011 Split-mouth study
Dyer 1982 Not RCT
Dénes 1988 Assessed DMFS not white spot lesions
Dénes 1989 Assessed DMFS not white spot lesions
Dénes 1991 Assessed DMFS not white spot lesions
Enerbäck 2019 Did not follow to the end of orthodontic treatment only 1 year from start and outcomes not rele-
vant for this review (caries risk and bacteria levels)
Farhadian 2008 Not RCT
Fricker 1985 Not RCT
Fricker 1987 Not RCT
Gaworski 1999 Not RCT
Geiger 1988 Not RCT
Geiger 1992 Not RCT
Gillgrass 2001 Split-mouth study
Gorton 2003 Ex vivo study - outcomes measured on extracted teeth
Hirschfield 1978 Not RCT
Leizer 2010 Appears to be allocation based on study number (odd or even) and teeth allocated alternately. CCT.
No reply to emails sent to contact author
Maijer 1988 Not RCT
Marcusson 1997 Split-mouth study
Marini 1999 Duration of intervention 12 months but outcomes assessed at end of treatment period not at the
end of treatment with fixed orthodontic appliances
Mattick 2001 Split-mouth RCT
Millett 1999 Split-mouth study, allocation of each side to treatment by alternation. Not RCT
Millett 2000 Split-mouth study, allocation of each side to treatment by alternation. Not RCT
Mitchell 1992 Split-mouth study, no random allocation. Author contacted
Neumann 1976 Abstract only. Insufficient data, no subsequent publication identified
O'Reilly 1987 Ex vivo study - outcomes measured on extracted teeth
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Study Reason for exclusion
Ogaard 1986 Ex vivo study - outcomes measured on extracted teeth
Ogaard 1992 Random allocation to treatment not mentioned. Author contacted
Ogaard 1996 Not RCT. Author contacted
Ogaard 1997 Effect of fluoride confounded by co-intervention. Both groups had fluoride varnish. The experimen-
tal group had in addition an antimicrobial varnish therefore the study looks at the efficacy of the
antimicrobial varnish rather than the fluoride varnish
Ogaard 2001 Effect of fluoride confounded by co-intervention. 2 randomised groups and 1 non-randomised con-
trol group. Both randomised groups received fluoride varnish every 12 weeks, fluoride exposure
was not different between the 2 randomised groups
Pascotto 2004 Ex vivo study - outcomes measured on extracted teeth
Robertson 2011 Duration of intervention 12 months but outcomes assessed at end of treatment period not at the
end of treatment with fixed orthodontic appliances
Salzmann 1976 Abstract only. No subsequent publication identified
Shan 2008 Split-mouth study
Shannon 1978 Allocation method not stated. Unable to contact the authors
Shannon 1979 Allocation method not stated. Unable to contact the authors
Sköld-Larsson 2013 Intervention period was short (12 weeks) and assessments were not undertaken at the start and
end of orthodontic treatment
Sonis 1989 Not RCT
Trimpeneers 1996 Split-mouth study. All participants had the same product used in the same quadrants. Not RC-
T.Contacted author (LR Dermaut). Unable to provide further data for statistical analysis
Turner 1993 Split-mouth study
Twetman 1997 Split-mouth study
Ullsfoss 1994 Both groups had fluoride mouthrinse. The experimental group had in addition an antimicrobial
mouthrinse, therefore the study looks at the efficacy of the antimicrobial mouthrinse rather than
the fluoride mouthrinse
Underwood 1989 Random allocation not mentioned. Brackets on alternate teeth bonded with each adhesive. Not
RCT
van der Linden 1998 Split-mouth study
Vivaldi-Rodrigues 2006 Split-mouth study
Wenderoth 1999 Not RCT
CCT = controlled clinical trial; DMFS/DMFT = decayed, missing and filled surfaces/teeth; RCT = randomised controlled trial.
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Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Efficacy of the fluoride varnish enamelast for preventing white spot lesions and gingivitis in fixed
orthodontic treatment of patients with low to moderate caries risk - a randomised controlled trial
Methods Single centre (specialist practice, Memmingen Germany), triple-blind, RCT, 2-arm parallel groups,
assessing superiority
Participants Target sample size: 104
Interventions Group 1: Intervention 1: instructions on home oral hygiene and nutrition; Intervention 2: study-in-
dependent fixed orthodontic therapy in buccal technique; Intervention 3: 1-time application of a
placebo varnish at the beginning of fixed therapy (once at 6 months)
Group 2: Intervention 1: instructions on home oral hygiene and nutrition; Intervention 2: study-in-
dependent fixed orthodontic therapy in buccal technique; Intervention 3: 1-time application of flu-
oride varnish enamelast at the beginning of fixed therapy (once at 6 months)
Outcomes Measurement of white spot/caries progression by clinical-visual assessment of the extent of the
enamel/demineralisation/initial caries on the buccal tooth surfaces with a score value (Likert
scale). Time points: T-1, recruitment: appointment at least 30 days before the start of the fixed or-
thodontic therapy; T0, baseline: after bonding the brackets and removing the excess material; T1, 3
months: after 3 months of fixed therapy; T2, 6 months: after 6 months of fixed therapy (in case of a
coincidence with the therapy end before debonding)
Modified plaque index according to Silness and Loe (MPI)
Gingival index according to Silness and Loe (1963)
Starting date Date of first enrolment: 12 June 2017
Contact information Christian Kirschneck (christian.kirschneck@ukr.de)
Notes Contacted author on 21 August 2018 who responded straight away. Only planning to collect data at
6 months, not at the end of treatment, so we will probably not include study but will contact again




Trial name or title Efficacy of Fluor-Protector S fluoride varnish for preventing white spot lesions and gingivitis in fixed
orthodontic treatment of patients with high risk of caries - a randomised controlled trial
Methods Single centre (specialist practice, Memmingen Germany), triple-blind, RCT, 2-arm parallel groups,
assessing superiority
Participants Target sample size: 44
Interventions Group 1: Intervention 1: instructions on home oral hygiene and nutrition; Intervention 2: study-in-
dependent fixed orthodontic therapy in buccal technique; Intervention 3: application of a placebo
varnish at the beginning of fixed therapy and after 3 months (once at 3 months)
Group 2: Intervention 1: instructions on home oral hygiene and nutrition; Intervention 2: study-in-
dependent fixed orthodontic therapy in buccal technique; Intervention 3: application of Fluor Pro-
tector S varnish at the beginning of fixed therapy and after 3 months (once at 3 months)
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Outcomes Measurement of white spot/caries progression by clinical-visual assessment of the extent of the
enamel/demineralisation/initial caries on the buccal tooth surfaces with a score value (Likert
scale). Time points: T-1, recruitment: appointment at least 30 days before the start of the fixed or-
thodontic therapy; T0, baseline: after bonding the brackets and removing the excess material; T1, 3
months: after 3 months of fixed therapy; T2, 6 months: after 6 months of fixed therapy (in case of a
coincidence with the therapy end before debonding)
Modified plaque index according to Silness and Loe (MPI)
Gingival index according to Silness and Loe (1963)
Starting date Date of first enrolment: 12 June 2017
Contact information Christian Kirschneck (christian.kirschneck@ukr.de)
Notes Contacted author on 21 August 2018 who responded straight away. Only planning to collect data at
6 months, not at the end of treatment, so we will probably not include study but will contact again




Trial name or title A clinical trial of comparing the effect of fluoride varnish and chlorhexidine gel on white spots and
gingival indexes in orthodontic patients
Methods Single centre (Faculty of Dentistry, Isfahan, Iran), RCT, 4-arm parallel groups, assessing superiority
Participants Target sample size: 40
Interventions Intervention 1: fluoride varnish 5% which is made in USA will be applied on teeth every 3 months
until 9 months
Intervention 2: chlorhexidine gel 0.2% which is made in Spain, in dose of 5 mg will be applied on
teeth every 3 months until 9 months
Intervention 3: placebo group: sorbitol solution (70% W/W) will be applied on teeth every 3 months
until 9 months
Intervention 4: control group: no intervention
Outcomes States 3 primary outcomes and no secondary outcomes:
White spots. Time points: before the first intervention, 3, 6 and 9 months after that and before the
intervention in each time. Method of measurement: visual inspection with intraoral examination
mirror - not clear what index will be used or by whom
Gingival index. Time points: before the first intervention, 3, 6 and 9 months after that and before
the intervention in each time. Method of measurement: dental probe
Plaque index. Time points: before the first intervention, 3, 6 and 9 months after that and before the
intervention in each time. Method of measurement: visual inspection
Starting date 20 January 2017
Contact information Navid Yaraghi (alavi@dnt.mui.ac.ir)
Notes Contacted on 21 August 2018 - awaiting a reply
IRCT2016122531558N1 
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ppm = parts per million; RCT = randomised controlled trial; W/W = weight/weight.
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Professionally-applied F varnish versus non-F (placebo) varnish





Statistical method Effect size
1 Number of participants with new DLs 2 405 Risk Ratio (M-H, Random, 95%
CI)
0.52 [0.14, 1.93]
2 Number of participants with more severe DLs
(scores 3 or 4 versus scores 1 or 2)





Analysis 1.1.   Comparison 1 Professionally-applied F varnish versus non-
F (placebo) varnish, Outcome 1 Number of participants with new DLs.
Study or subgroup F varnish Non-F varnish Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Sonesson 2019 25/75 25/73 52.07% 0.97[0.62,1.53]
Stecksén-Blicks 2007 9/132 32/125 47.93% 0.27[0.13,0.54]
   
Total (95% CI) 207 198 100% 0.52[0.14,1.93]
Total events: 34 (F varnish), 57 (Non-F varnish)  
Heterogeneity: Tau2=0.8; Chi2=9.91, df=1(P=0); I2=89.91%  
Test for overall effect: Z=0.97(P=0.33)  
Favours F varnish 1000.01 100.1 1 Favours non-F varnish
 
 
Analysis 1.2.   Comparison 1 Professionally-applied F varnish versus non-F (placebo) varnish,
Outcome 2 Number of participants with more severe DLs (scores 3 or 4 versus scores 1 or 2).
Study or subgroup F varnish Non-F varnish Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Sonesson 2019 9/75 19/73 100% 0.46[0.22,0.95]
   
Total (95% CI) 75 73 100% 0.46[0.22,0.95]
Total events: 9 (F varnish), 19 (Non-F varnish)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.09(P=0.04)  
Favours F varnish 1000.01 100.1 1 Favours non-F varnish
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Comparison 2.   12,500 ppm F (NaF/olaflur/dectaflur) gel versus 0 ppm F placebo gel




Statistical method Effect size
1 Number of participants with new DLs 1 312 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.76, 1.27]
 
 
Analysis 2.1.   Comparison 2 12,500 ppm F (NaF/olaflur/dectaflur) gel versus
0 ppm F placebo gel, Outcome 1 Number of participants with new DLs.
Study or subgroup Amine gel Placebo
control gel
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Jost-Brinkman 2017 66/156 67/156 100% 0.99[0.76,1.27]
   
Total (95% CI) 156 156 100% 0.99[0.76,1.27]
Total events: 66 (Amine gel), 67 (Placebo control gel)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.91)  
Favours amine fluoride 20.5 1.50.7 1 Favours placebo control
 
 
Comparison 3.   12,300 ppm F APF foam versus 0 ppm F placebo foam




Statistical method Effect size
1 Number of participants with new DLs 1 95 Risk Ratio (M-H, Random, 95% CI) 0.26 [0.11, 0.57]
 
 
Analysis 3.1.   Comparison 3 12,300 ppm F APF foam versus 0 ppm
F placebo foam, Outcome 1 Number of participants with new DLs.
Study or subgroup 12,300 ppm
F APF foam
0 ppm F foam Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Jiang 2013 6/48 23/47 100% 0.26[0.11,0.57]
   
Total (95% CI) 48 47 100% 0.26[0.11,0.57]
Total events: 6 (12,300 ppm F APF foam), 23 (0 ppm F foam)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.33(P=0)  
Favours 12,300 ppm F foam 1000.01 100.1 1 Favours 0 ppm F foam
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Comparison 4.   5000 ppm F toothpaste versus 1450 ppm F toothpaste




Statistical method Effect size
1 Number of participants with new DLs 1 380 Risk Ratio (M-H, Random, 95% CI) 0.68 [0.46, 1.00]
 
 
Analysis 4.1.   Comparison 4 5000 ppm F toothpaste versus 1450
ppm F toothpaste, Outcome 1 Number of participants with new DLs.
Study or subgroup 5000 ppm F 1450 ppm F Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Sonesson 2014 34/188 51/192 100% 0.68[0.46,1]
   
Total (95% CI) 188 192 100% 0.68[0.46,1]
Total events: 34 (5000 ppm F), 51 (1450 ppm F)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.96(P=0.05)  
Favours 5000 ppm F 20.5 1.50.7 1 Favours 1400 ppm F
 
 
Comparison 5.   250 ppm F mouthrinse (100 ppm AmF/150 ppm NaF) versus 0 ppm F placebo mouthrinse




Statistical method Effect size
1 Number of participants with new DLs 1 81 Risk Ratio (M-H, Random, 95% CI) 0.65 [0.37, 1.17]
 
 
Analysis 5.1.   Comparison 5 250 ppm F mouthrinse (100 ppm AmF/150 ppm NaF)
versus 0 ppm F placebo mouthrinse, Outcome 1 Number of participants with new DLs.
Study or subgroup 250 ppm F 0 ppm F Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
van der Kaaij 2015 11/36 21/45 100% 0.65[0.37,1.17]
   
Total (95% CI) 36 45 100% 0.65[0.37,1.17]
Total events: 11 (250 ppm F), 21 (0 ppm F)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.42(P=0.15)  
Favours 250 ppm F 50.2 20.5 1 Favours 0 ppm F
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Comparison 6.   1400 ppm/250 ppm F (AmF/SnF) versus 1400 ppm/250 ppm F (NaF) toothpaste/mouthrinse
combinations





Statistical method Effect size
1 White spot index 1 97 Mean Difference (IV, Random, 95% CI) -0.05 [-0.10, 0.00]
2 Visible plaque index 1 97 Mean Difference (IV, Random, 95% CI) -0.09 [-0.18, -0.00]
3 Gingival bleeding index 1 97 Mean Difference (IV, Random, 95% CI) -0.07 [-0.15, 0.01]
 
 
Analysis 6.1.   Comparison 6 1400 ppm/250 ppm F (AmF/SnF) versus 1400 ppm/250
ppm F (NaF) toothpaste/mouthrinse combinations, Outcome 1 White spot index.
Study or subgroup Favours AmF/SnF Favours NaF Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Ogaard 2006 50 0 (0.1) 47 0.1 (0.2) 100% -0.05[-0.1,0]
   
Total *** 50   47   100% -0.05[-0.1,0]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.78(P=0.07)  
Favours AmF/SnF 0.20.1-0.2 -0.1 0 Favours NaF
 
 
Analysis 6.2.   Comparison 6 1400 ppm/250 ppm F (AmF/SnF) versus 1400 ppm/250
ppm F (NaF) toothpaste/mouthrinse combinations, Outcome 2 Visible plaque index.
Study or subgroup Favours AmF/SnF Favours NaF Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Ogaard 2006 50 0 (0.2) 47 0.1 (0.2) 100% -0.09[-0.18,-0]
   
Total *** 50   47   100% -0.09[-0.18,-0]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.06(P=0.04)  
Favours AmF/SnF 10.5-1 -0.5 0 Favours NaF
 
 
Analysis 6.3.   Comparison 6 1400 ppm/250 ppm F (AmF/SnF) versus 1400 ppm/250 ppm
F (NaF) toothpaste/mouthrinse combinations, Outcome 3 Gingival bleeding index.
Study or subgroup Favours AmF/SnF Favours NaF Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Ogaard 2006 50 0 (0.2) 47 0.1 (0.2) 100% -0.07[-0.15,0.01]
   
Total *** 50   47   100% -0.07[-0.15,0.01]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.72(P=0.09)  
Favours AmF/SnF 0.20.1-0.2 -0.1 0 Favours NaF
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Comparison 7.   Resin-modified glass ionomer cement (RM-GIC) versus light-cured composite resin (LCC)





Statistical method Effect size
1 Number of participants with new DLs 1 173 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.69, 1.99]
2 Number of participants with more severe DLs
of aesthetic concern
1 173 Risk Ratio (M-H, Random, 95% CI) 1.18 [0.45, 3.12]
 
 
Analysis 7.1.   Comparison 7 Resin-modified glass ionomer cement (RM-GIC) versus
light-cured composite resin (LCC), Outcome 1 Number of participants with new DLs.
Study or subgroup RM-GIC LCC Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Benson 2019 23/88 19/85 100% 1.17[0.69,1.99]
   
Total (95% CI) 88 85 100% 1.17[0.69,1.99]
Total events: 23 (RM-GIC), 19 (LCC)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.58(P=0.56)  
Favours RM-GIC 20.5 1.50.7 1 Favours LCC
 
 
Analysis 7.2.   Comparison 7 Resin-modified glass ionomer cement (RM-GIC) versus light-cured
composite resin (LCC), Outcome 2 Number of participants with more severe DLs of aesthetic concern.
Study or subgroup RM-GIC LCC Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Benson 2019 8/85 7/88 100% 1.18[0.45,3.12]
   
Total (95% CI) 85 88 100% 1.18[0.45,3.12]
Total events: 8 (RM-GIC), 7 (LCC)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.34(P=0.73)  
Favours RM-GIC 1000.01 100.1 1 Favours LCC
 
 
Comparison 8.   Intraoral F-releasing glass bead device versus F mouthrinse only




Statistical method Effect size
1 Number of participants with new DLs 1 37 Risk Ratio (M-H, Random, 95% CI) 1.51 [0.73, 3.10]
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Analysis 8.1.   Comparison 8 Intraoral F-releasing glass bead device versus
F mouthrinse only, Outcome 1 Number of participants with new DLs.
Study or subgroup Intraoral
F device
F mouthrinse Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Luther 2005 10/18 7/19 100% 1.51[0.73,3.1]
   
Total (95% CI) 18 19 100% 1.51[0.73,3.1]
Total events: 10 (Intraoral F device), 7 (F mouthrinse)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.12(P=0.26)  
Favours intraoral device 500.02 100.1 1 Favours F mouthrinse
 
 
A D D I T I O N A L   T A B L E S
Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment (Review)











































































Patient or population: orthodontic patients (any age)
Setting: dental clinics in Germany and Israel and home use
Intervention: 12,500 ppm F (NaF/olaflur/dectaflur) fluoride gel
Comparison: 0 ppm F placebo gel






















Number of participants with new
DLs (new DLs)
Assessed with: clinical examina-
tion
















The evidence is very uncertain about the
effect of an amine fluoride gel compared
with a placebo gel on the number of pa-
tients wearing fixed orthodontic braces
with new DLs
Number of participants with
more severe DLs (severity of DLs)
None of the trials reported this outcome
Number of participants with ad-
verse effects (adverse effects)














Authors write "Most AEs (96.4%) were
unrelated to the study treatment. Only
a single AE (hay fever) was considered
related to the study treatment (place-
bo)." They go on to state "The use... for a
maximum of 32.5 months was not asso-
ciated with any unexpected ARs or AEs.
Thus, there are no safety issues to be
considered for long-term use of elmex®
gel"
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
AE: adverse effects; CI: confidence interval; DLs: demineralised lesions; F: fluoride; NaF: sodium fluoride; ppm: parts per million; RCT: randomised controlled trial; RR: risk
ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Table 1.   Summary of findings for 12,500 ppm F (NaF/olaflur/dectaflur) fluoride gel compared to 0 ppm F placebo gel for preventing early tooth decay



















































































































Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
Table 1.   Summary of findings for 12,500 ppm F (NaF/olaflur/dectaflur) fluoride gel compared to 0 ppm F placebo gel for preventing early tooth decay
(demineralised lesions) during fixed brace treatment  (Continued)
aDowngraded 1 level due to single study at unclear risk of bias (Jost-Brinkman 2017).
bDowngraded 1 level for imprecision (insufficient number of participants with new DLs (guidance 300 to 400 events)).
cDowngraded 1 level for publication bias (data collection for the trial was completed in 2011. The results were obtained from the study report that was published in 2016, but
not yet submitted to a peer-reviewed journal).
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Patient or population: orthodontic patients (any age)
Setting: home use
Intervention: 1400 ppm/250 ppm F (amineF/SnF) toothpaste/mouthrinse
Comparison: 1400 ppm/250 ppm F (NaF) toothpaste/mouthrinse
Anticipated absolute effects* (95% CI)Outcomes
Risk with 1400 ppm/250
ppm F (NaF) tooth-
paste/mouthrinse

















pants with new DLs
(new DLs)
Follow-up: 1.5 years
Outcome not reported. White spot lesion index, visible
plaque index and gingival bleeding index reported in-
stead: MD 0.05 lower (0.10 lower to 0) white spot index,
MD 0.09 lower (0.18 lower to 0) visible plaque index, MD
0.07 lower (0.15 lower to 0.01 higher) gingival bleed-



















































Table 2.   Summary of findings for 1400 ppm/250 ppm F (amine F/SnF) toothpaste/mouthrinse compared to 1400
ppm/250 ppm F (NaF) toothpaste/mouthrinse for preventing early tooth decay (demineralised lesions) during fixed
brace treatment 
Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment (Review)
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Number of partici-
pants with more se-
vere DLs (severity of
DLs)





None of the trials reported this outcome
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of
the intervention (and its 95% CI).
CI: confidence interval; DLs: demineralised lesions; F: fluoride; MD: mean difference; NaF: sodium fluoride; ppm: parts per million;
RCT: randomised controlled trial; SnF: stannous fluoride.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the ef-
fect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the
effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the
estimate of effect
Table 2.   Summary of findings for 1400 ppm/250 ppm F (amine F/SnF) toothpaste/mouthrinse compared to 1400
ppm/250 ppm F (NaF) toothpaste/mouthrinse for preventing early tooth decay (demineralised lesions) during fixed
brace treatment  (Continued)
aDowngraded 1 level due to single study assessed at unclear risk of bias (Ogaard 2006).
bDowngraded 1 level for indirectness (outcomes assessed were not the most useful for answering this question).
cDowngraded 1 level for imprecision (insufficient number of participants with new DLs (guideline 300 to 400)).
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Patient or population: orthodontic patients (any age)
Setting: teaching hospital in UK and home use
Intervention: intraoral fluoride-releasing glass bead device
Comparison: 250 ppm F mouthrinse






















Number of participants with new DLs
(new DLs)



















The evidence is very uncertain
about the effect of intraoral fluo-
ride-releasing glass bead devices
compared with daily 250 ppm F
mouthrinses on the number of pa-
tients wearing a fixed orthodontic
brace with new DLs
Number of participants with more se-
vere DLs (severity of DLs)
None of the trials reported this outcome
Number of participants with adverse
effects (adverse effects)
Follow-up: 19 months





Current design of fluoride glass
bead inadequate. The authors
write "an improved method of at-
tachment is needed before it can
be established whether FGBs (fluo-
ride glass beads) are more effective
than FR (fluoride mouthrinse)."c
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; DLs: demineralised lesions; F: fluoride; ppm: parts per million; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
Table 3.   Summary of findings for intraoral fluoride-releasing glass bead device compared to 250 ppm F mouthrinse for preventing early tooth decay



















































































































aDowngraded 2 levels due to single study at high risk of bias (high attrition (47%)) (Luther 2005).
bDowngraded 1 level for imprecision (insufficient number of participants with new DLs (guidance 300 to 400 events)).
cHigh attrition partly due to breaks of the glass beads. The authors write "Some patients in the FGB (fluoride glass bead) group experienced a large number of bead breakages,
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A P P E N D I C E S
Appendix 1. Cochrane Oral Health's Trials Register search strategy
Cochrane Oral Health's Trials Register is available via the Cochrane Register of Studies. For information on how the register is compiled,
see oralhealth.cochrane.org/trials
From December 2016, searches of the Cochrane Oral Health's Trials Register for this review were undertaken using the Cochrane Register
of Studies and the search strategy below:
1. orthodontic*
2. (cariostatic* OR fluoride* OR naf OR "glass ionomer*" OR "cermet cement*" OR compomer* OR "composite resin*")
3. ("dental enamel solubility" OR caries OR "dental fissures" OR demineriali* OR reminerali* OR decalcifi* OR "white spot*" or lesion*)
4. #1 AND #2 AND #3
Previous searches were undertaken using the Procite software, and the search strategy below:
(orthodontic* AND (cariostatic* OR fluoride* OR naf OR "glass ionomer*" OR "cermet cement*" OR compomer* OR "composite resin*")
AND ("dental enamel solubility" OR caries OR "dental fissures" OR demineriali* OR reminerali* OR decalcifi* OR "white spot*" or lesion*))
Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL) search strategy
#1 MeSH descriptor Orthodontics explode all trees
#2 orthodontic*
#3 (#1 OR #2)
#4 MeSH descriptor Sodium Fluoride explode all trees
#5 MeSH descriptor Fluorides, Topical explode all trees
#6 fluoride*
#7 topical next fluoride*
#8 NaF
#9 MeSH descriptor Glass Ionomer Cements, this term only
#10 glass next ionomer*
#11 (#4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 MeSH descriptor Dental Enamel Solubility explode all trees
#13 MeSH descriptor Tooth Demineralization explode all trees
#14 reminerali* or deminerali* or decalcif*
#15 white next spot*
#16 (#12 OR #13 OR #14 OR #15)
#17 (#3 AND #11 AND #16)




4. exp SODIUM FLUORIDE/
5. exp FLUORIDES TOPICAL/
6. fluoride$.mp.
7. NaF.ti,ab.
8. Glass Ionomer Cements/
9. (glass adj ionomer$).mp.
10.or/4-9
11.exp DENTAL ENAMEL SOLUBILITY/
12.TOOTH DEMINERALIZATION/
13.(reminerali$ or deminerali$ or decalcif$).mp.
14.((white adj spot$) or lesion$).mp.
15.11 or 12 or 13 or 14
16.3 and 10 and 15
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This subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials (RCTs) in
MEDLINE: sensitivity- maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of theCochrane Hand-
book for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011) (Lefebvre 2011).
1. randomized controlled trial.pt.








10.exp animals/ not humans.sh.
11.9 not 10
Appendix 4. Embase Ovid search strategy
1. exp ORTHODONTICS/
2. orthodontic$.mp.
3. 1 or 2
4. exp SODIUM FLUORIDE/
5. exp FLUORIDES TOPICAL/
6. fluoride$.mp.
7. NaF.ti,ab.
8. Glass Ionomer Cements/
9. (glass adj ionomer$).mp.
10.or/4-9
11.exp DENTAL ENAMEL SOLUBILITY/
12.TOOTH DEMINERALIZATION/
13.(reminerali$ or deminerali$ or decalcif$).mp.
14.((white adj spot$) or lesion$).mp.
15.or/11-14
16.3 and 10 and 15
This subject search was linked to an adapted version of the Cochrane Centralised Search Project filter for identifying RCTs in Embase Ovid
(see www.cochranelibrary.com/central/central-creation for information:
1. Randomized controlled trial/





7. (compare or compared or comparison).ti.
8. ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab.
9. (open adj label).ti,ab.
10.((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.
11.double blind procedure/
12.parallel group$1.ti,ab.
13.(crossover or cross over).ti,ab.
14.((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or partici-
pant$1)).ti,ab.
15.(assigned or allocated).ti,ab.
16.(controlled adj7 (study or design or trial)).ti,ab.
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20.(exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.)
21.19 not 20
Appendix 5. US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) and the WHO International
Clinical Trials Registry Platform search strategy
orthodontic and fluoride
W H A T ' S   N E W
 
Date Event Description
13 March 2019 New citation required and conclusions
have changed
Changes to author byline. Review update including 7 new studies
bringing the total to 10 included studies. Conclusions changed.
1 February 2019 New search has been performed Searches updated to 1 February 2019.
 
H I S T O R Y
Protocol first published: Issue 3, 2002
Review first published: Issue 3, 2004
 
Date Event Description
3 December 2013 New citation required and conclusions
have changed
Changes to inclusion criteria, 3 parallel-group studies added and
14 previously included studies now excluded. New methods im-
plemented and 'Summary of findings' table added. Conclusions
changed.
1 May 2013 New search has been performed Searches updated to January 2013.
 
C O N T R I B U T I O N S   O F   A U T H O R S
Philip Benson wrote the original protocol and co-ordinated the review and subsequent updates. Philip Benson, Fiona Dyer, Peter Germain,
Declan Millett and Nicola Parkin independently and in duplicate assessed the eligibility of trials, extracted data and assessed the quality
and risk of bias. Philip Benson and Fiona Dyer (2019 update) contacted authors, entered the data, carried out the statistical analysis (with
help from Helen Worthington) and wrote the review. Declan Millett proofread the review.
D E C L A R A T I O N S   O F   I N T E R E S T
Three of the review authors (Philip Benson, Declan Millett and Fiona Dyer) were authors for one of the included studies (Benson 2019). The
evaluation of this study, including data extraction and methodological quality assessments, was reviewed and confirmed by two authors
not involved in this study (Nicola Parkin and Peter Germain).
S O U R C E S   O F   S U P P O R T
Internal sources
• School of Clinical Dentistry, University of Sheffield, UK.
• Dental School, University College Cork, Ireland.
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External sources
• Cochrane Oral Health Global Alliance, Other.
The production of Cochrane Oral Health reviews has been supported financially by our Global Alliance since 2011 (oral-
health.cochrane.org/partnerships-alliances). Contributors over the past year have been the American Association of Public Health Den-
tistry, USA; AS-Akademie, Germany; the British Association for the Study of Community Dentistry, UK; the British Society of Paediatric
Dentistry, UK; the Canadian Dental Hygienists Association, Canada; the Centre for Dental Education and Research at All India Institute
of Medical Sciences, India; the National Center for Dental Hygiene Research & Practice, USA; New York University College of Dentistry,
USA; NHS Education for Scotland, UK; and the Swiss Society for Endodontology, Switzerland.
• National Institute for Health Research (NIHR), UK.
This project was supported by the NIHR, via Cochrane Infrastructure funding to Cochrane Oral Health. The views and opinions expressed
are those of the authors and not necessarily those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health and
Social Care.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
In the 2013 update of this review, controlled clinical trials (quasi-randomised) were excluded.
A point of clarification was added to the inclusion criteria for this review. For a randomised controlled trial to be included, demineralised
lesions (DLs) must be assessed on teeth remaining in the mouth. Studies that evaluated demineralisation of extracted teeth were excluded
from the 2013 update of this review because they measured the effects of short-term exposure to fluoride (four to six weeks between
application and extraction of the teeth). Furthermore, it was decided that evaluation of demineralisation must take place at the end of
treatment with fixed orthodontic appliances (debonding).
As stated in the Discussion of the 2013 update of this review, the use of a split-mouth study design to evaluate these interventions is
potentially inappropriate. It is unlikely that the fluoride released will be confined to only the quadrants or the specific teeth in which the
experimental material has been placed, and some 'contamination' of teeth in the control quadrants is inevitable. This will reduce the
difference in outcome between experimental and control teeth and will reduce the power of the trial to find a difference. Indeed split-
mouth studies included in the previous version of this review found no difference between teeth with fluoridated bracket adhesives and
those without, supporting the view that this design is inappropriate for evaluating topical fluorides. Split-mouth studies were excluded
from the 2013 update of this review, and the Methods section of this review was amended to remove methods that were used to deal with
split-mouth studies.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Dental Caries   [*prevention & control];   Fluorides   [administration & dosage]   [*therapeutic use];   Mouthwashes   [*therapeutic use];
  Orthodontic Brackets  [*adverse eGects];  Randomized Controlled Trials as Topic
MeSH check words
Humans
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